<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Surg</journal-id><journal-id journal-id-type="iso-abbrev">Int J Surg</journal-id><journal-id journal-id-type="pmc-domain-id">2035</journal-id><journal-id journal-id-type="pmc-domain">lwwopen</journal-id><journal-id journal-id-type="publisher-id">JS9</journal-id><journal-title-group><journal-title>International Journal of Surgery (London, England)</journal-title></journal-title-group><issn pub-type="ppub">1743-9191</issn><issn pub-type="epub">1743-9159</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Lippincott Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430899</article-id><article-id pub-id-type="pmcid-ver">PMC12430899.1</article-id><article-id pub-id-type="pmcaid">12430899</article-id><article-id pub-id-type="pmcaiid">12430899</article-id><article-id pub-id-type="pmid">40540448</article-id><article-id pub-id-type="doi">10.1097/JS9.0000000000002741</article-id><article-id pub-id-type="publisher-id">IJS-D-25-01598</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Experimental Research</subject></subj-group></article-categories><title-group><article-title>Enhancing early mortality prediction for sepsis-associated acute respiratory distress syndrome patients via optimized machine learning algorithm: development and multiple databases&#8217; validation of the SAFE-Mo</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4248-9532</contrib-id><name name-style="western"><surname>Jiang</surname><given-names initials="L">Luofeng</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><email>jiangluofeng1999@163.com</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8299-427X</contrib-id><name name-style="western"><surname>Yu</surname><given-names initials="C">Chuting</given-names></name><degrees>PhD</degrees><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xie</surname><given-names initials="C">Chaoran</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><email>xcr240505@163.com</email></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zheng</surname><given-names initials="Y">Yongjun</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref><email>smmuzhengyongjun@163.com</email></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Xia</surname><given-names initials="Z">Zhaofan</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref><email>xiazhaofan-smmu@163.com</email></contrib><aff id="aff1"><label>a</label>Department of Burn Surgery, The First Affiliated Hospital of Naval Medical University, Shanghai, China</aff><aff id="aff2"><label>b</label>Research Unit of Key Techniques for Treatment of Burns and Combined Burns and Trauma Injury, Chinese Academy of Medical Sciences, Shanghai, China</aff><aff id="aff3"><label>c</label>Department of Digestive, The First Affiliated Hospital of Naval Medical University, Shanghai, China</aff></contrib-group><author-notes><corresp id="COR0001"><label>*</label>Corresponding authors. Address: Department of Burn Surgery, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China. Email: <email>smmuzhengyongjun@163.com</email> (Y. Zheng); Department of Burn Surgery, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China. Tel.: +86 2181873212. E-mail: <email>xiazhaofan-smmu@163.com</email> (Z. Xia).</corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>6</month><year>2025</year></pub-date><volume>111</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496813</issue-id><fpage>6008</fpage><lpage>6022</lpage><history><date date-type="received"><day>31</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>02</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0</ext-link> (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="js9-111-6008.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="js9-111-6008.pdf"/><abstract><sec><title>Background:</title><p>Acute respiratory distress syndrome (ARDS) is associated with high mortality, with sepsis accounts for 31&#8211;34% of cases. Given the global burden of sepsis (508 cases per 100&#160;000 person-years) and its association with 20% of all global deaths, early mortality prediction in patients with sepsis-associated ARDS is critical. This study developed and validated the Sepsis-associated ARDS Fatality Evaluation Model (SAFE-Mo), a machine learning (ML) model designed to predict early mortality in sepsis-associated ARDS patients, enabling earlier identification of high-risk individuals.</p></sec><sec><title>Methods:</title><p>Data were extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV, v3.0), eICU Collaborative Research Database (eICU CRD, v2.0), and Northwest ICU (NWICU, v0.1.0) using Structured Query Language (SQL). SAFE-Mo was constructed using ML algorithm (svmRadialSigma) focusing on median survival days among deceased patients as the primary outcome. The model&#8217;s performance was validated externally using the MIMIC-IV and eICU CRD database and compared against four commonly used clinical risk assessment models (acute physiology score III (APSIII), simplified acute physiology score II (SAPS II), sequential organ failure assessment (SOFA), Charlson comorbidity index (CCI)). Additionally, NWICU was used to further validate SAFE-Mo&#8217;s generalization. Discrimination, calibration, and clinical utility were evaluated using area under the curve (AUC), Decision Curve Analysis (DCA), and calibration curves.</p></sec><sec><title>Results:</title><p>SAFE-Mo demonstrated superior predictive capability of early mortality compared to traditional models. It showed the largest reasonable risk threshold probability range and highest net benefit. Calibration curves indicated a slight overestimation of mortality risk overall. With our simple SAFE-Mo web page, SAFE-Mo can assist clinicians in identifying high-risk patients early, like patients with unusually high levels of lactate in sepsis-associated ARDS, assessing prognosis, and facilitating risk-adjusted comparisons of center-specific outcomes. Practical advantages include guiding personalized treatment strategies, determining the need for aggressive interventions, and optimizing resource utilization.</p></sec><sec><title>Conclusion:</title><p>This study utilized the MIMIC-IV, eICU CRD, and NWICU databases to construct and validate a ML model, SAFE-Mo, which predicts early mortality in patients with sepsis-associated ARDS and outperforms traditional prediction models across all metrics. SAFE-Mo can guide clinicians to focus on critical indicators such as lactate, urine output, anion gap, and others, enabling appropriate measures to improve clinical outcomes for high-risk patients.</p></sec></abstract><kwd-group><kwd>acute respiratory distress syndrome</kwd><kwd>eICU CRD</kwd><kwd>machine learning</kwd><kwd>MIMIC-IV</kwd><kwd>NWICU</kwd><kwd>sepsis</kwd><kwd>sepsis-induced acute lung injury</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta><custom-meta><meta-name>SDC</meta-name><meta-value>T</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Acute respiratory distress syndrome (ARDS) is an acute, life-threatening condition characterized by noncardiogenic pulmonary edema, severe hypoxemia, and decreased lung compliance. Its global annual incidence is estimated at 1.5&#8211;75 cases per 100&#160;000 person-years, with mortality rates as high as 46.1%<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref>]</sup>. Sepsis is an uncontrolled inflammatory response to infection. According to the Global Burden of Disease Study analysis for 1990&#8211;2017, the age-standardized incidence of sepsis in 2017 was 508.4 per 100&#160;000 person-years, and at least 20% of all deaths were sepsis-related<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup>. Sepsis is one of the most common causes of ARDS, with approximately 31.4&#8211;33.8% of sepsis patients developing ARDS<sup>[<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref>]</sup>. The coexistence of sepsis and ARDS markedly worsens patient outcomes<sup>[<xref rid="R4" ref-type="bibr">4</xref>-<xref rid="R6" ref-type="bibr">6</xref>]</sup>. Notably, most patients with sepsis-associated ARDS face significant challenges, characterized by a high short-term mortality rate that remains a pressing concern in clinical practice<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R7" ref-type="bibr">7</xref>]</sup>. These intertwined epidemiological features underscore the need for early risk identification in patients with sepsis-associated ARDS. Accurate prediction of patient outcomes&#8212;thereby facilitating timely adjustments in treatment paradigms&#8212;has become an urgent priority for clinicians.</p><p>Recent advancements in machine learning (ML) have garnered considerable attention within the medical community<sup>[<xref rid="R8" ref-type="bibr">8</xref>]</sup>. Compared to traditional logistic regression or Cox proportional hazards models, ML techniques exhibit superior performance in disease prediction and classification<sup>[<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref>]</sup>. However, existing studies on ML applications for predicting outcomes in sepsis-associated ARDS still present opportunities for improvement<sup>[<xref rid="R11" ref-type="bibr">11</xref>&#8211;<xref rid="R13" ref-type="bibr">13</xref>]</sup>. Currently, these studies exhibit one or more of the following specific limitations: (1) reliance on outdated database versions; (2) validation on a single cohort with a limited sample size; (3) lack of publicly available source code, compromising transparency; (4) suboptimal area under the curve (AUC) performance; (5) absence of clinical validation, precluding immediate application. These shortcomings underscore the imperative for further research aimed at improving predictive accuracy and enhancing the overall reliability and robustness of the findings.</p><p>To address these challenges, a ML -based prediction model was developed, focusing on median survival days among deceased patients as the primary outcome. The objective was to identify characteristics associated with short-term mortality in patients with sepsis-associated ARDS, thereby enabling earlier identification and potentially reducing short-term mortality rates. In pursuit of this goal, multiple ML algorithms and multiple independent databases were employed to construct and validate the sepsis-associated ARDS fatality evaluation model (SAFE-Mo). It is anticipated that SAFE-Mo will not only predict short-term mortality effectively but also contribute to the development of more effective assessment criteria for subsequent clinical management. Besides, our study is compliant with the TITAN Guidelines 2025&#8212;governing declaration and use of AI<sup>[<xref rid="R14" ref-type="bibr">14</xref>]</sup>.</p><p>The establishment of SAFE-Mo represents a step towards improving the prognosis and quality of life for patients suffering from sepsis-associated ARDS. Through precise predictions and early interventions, this study aims to provide a robust foundation for enhancing clinical decision-making processes and ultimately improving patient outcomes.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Data source</title><p>All the clinical data of the patients with sepsis in this study were obtained from the source: the MIMIC-IV (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://physionet.org" ext-link-type="uri">https://physionet.org</ext-link>) v3.0<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> database, the eICU (CRD, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://physionet.org" ext-link-type="uri">https://physionet.org</ext-link>) v2.0<sup>[<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R17" ref-type="bibr">17</xref>]</sup>, and the NWICU v0.1.0<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup>. One author completed the Collaborative Institutional Training Initiative (CITI) Program (No.50140789), obtained access to the MIMIC-IV, eICU CRD, and NWICU databases, and signed the data use agreement (Supplemental Digital Content, Table S1 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E462" ext-link-type="uri">http://links.lww.com/JS9/E462</ext-link>).</p></sec><sec><title>Participants</title><p>Patients diagnosed with sepsis according to the International Classification of Diseases, 9th Revision (ICD-9: 995.91, 995.92, 785.52), and meeting the diagnostic criteria for Acute Respiratory Distress Syndrome (ARDS)<sup>[<xref rid="R19" ref-type="bibr">19</xref>]</sup> were included in the study. Detailed inclusion criteria for each database are provided in Supplemental Digital Content, Table S2 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E463" ext-link-type="uri">http://links.lww.com/JS9/E463</ext-link>. Patients with missing values &gt;20% or patients younger than 18&#160;years of age or those who did not develop ARDS following the diagnosis of sepsis were excluded from the study. Given the hypothesis-driven epidemiological nature of the study, all patients eligible within the MIMIC-IV, eICU CRD, and NWICU database were included to maximize statistical power. Thus, a sample size calculation was not performed for this investigation.</p></sec><sec><title>Variable extraction</title><p>The following information of the patients from the MIMIC-IV, eICU CRD, and NWICU databases was used: (1) demographic characteristics (age, sex, admission type, insurance, marital status, race and degree), (2) vital signs (heart rate, respiratory rate, body temperature, systolic and diastolic blood pressure, mean blood pressure), (3) clinical risk assessment models (SOFA<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup>, APS III<sup>[<xref rid="R21" ref-type="bibr">21</xref>]</sup>, SAPS II<sup>[<xref rid="R22" ref-type="bibr">22</xref>]</sup> and CCI<sup>[<xref rid="R23" ref-type="bibr">23</xref>]</sup>). (4) Laboratory tests (SpO<sub>2</sub>, glucose, urine output, lactate, pH, SO<sub>2</sub>, PO<sub>2</sub>, PCO<sub>2</sub>, Arterial-Alveolar Oxygen Difference Calculation (A-aDO<sub>2</sub>-calc), Base excess, total CO<sub>2</sub>, calcium, potassium, sodium, platelets, WBC, albumin, anion gap, blood urea nitrogen (BUN), creatinine, abs monocytes, abs neutrophils, international normalized ratio (INR), prothrombin time (Pt), partial thromboplastin time (Ptt), alanine aminotransferase (ALT), alkaline phosphatase (ALP), aspartate aminotransferase (AST), and total bilirubin). (5) Comorbidities (myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic pulmonary disease, rheumatic disease, peptic ulcer disease, mild liver disease, diabetes without chronic complication (CC), diabetes with CC, paraplegia, renal disease, malignant cancer, severe liver disease, and metastatic solid tumor).</p></sec><sec><title>Data preprocessing</title><p>For laboratory tests, data from within 24&#160;hours prior to patient admission were included. Data points for each variable were selected based on the maximum and minimum values present within the datasets. In the context of disease scoring systems, only the initial test values utilized for analysis were included. To minimize bias due to missing data while preserving data integrity and ensuring robust statistical analyses, we first excluded variables with &gt;40% missing values. Subsequently, patients with &gt;20% missing data in the final cohort were excluded. Missing data were addressed using multiple imputation (MI) with the mice package<sup>[<xref rid="R24" ref-type="bibr">24</xref>]</sup> in R. To simulate potential clinical scenarios, we retained the 100% missing model variables in the NWICU dataset. Those variables (urine output, A-aDO<sub>2</sub>-calc max, A-aDO<sub>2</sub>-calc min, and potassium min) in NWICU were replaced with the median from MIMIC-IV training set. For the detection of imputation results, we employed several methods: the default method (meth), Bayesian linear regression (norm), bootstrap-based linear regression (norm.boot), linear regression prediction (norm.predict), classification and regression trees (CART), and random forests (rf). The optimal MI algorithm repeated 50 times and the average of the results was used to impute the missing data for subsequent analysis.</p></sec><sec><title>Feature selection</title><p>Multicollinearity was assessed using the Kappa statistic, with a kappa value of &#8804; 100 indicating minimal multicollinearity, 100&#160;&lt;&#160;kappa &#8804; 1000 suggesting moderate multicollinearity, and kappa &gt; 1000 indicating severe multicollinearity. To mitigate the impact of multicollinearity among multiple variables on model construction (Supplemental Digital Content, Fig. S2 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E461" ext-link-type="uri">http://links.lww.com/JS9/E461</ext-link>), we employed Lasso regression for data processing. Ten-fold cross-validation was employed to identify robustness of Lasso and acquire the minimum lambda value to select features for the following model establishment section.</p></sec><sec><title>Model establishment</title><p>To reflect the mean level of patient mortality risk, we used the median of survival time as a cutoff for model construction (Supplemental Digital Content, Fig. S1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E461" ext-link-type="uri">http://links.lww.com/JS9/E461</ext-link>). The MIMIC-IV was randomly split into training (80%) set and internal validation (20%) set. Stratified sampling (compared with random sampling in Supplemental Digital Content, Table S3 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E464" ext-link-type="uri">http://links.lww.com/JS9/E464</ext-link>) was performed using R package createDataPartition to ensure balanced class distribution in both training and validation sets for post hoc model evaluation. A total of 36 ML algorithms were employed to build the models, with AUC serving as the evaluation metric. Ten-fold cross-validation was used to assess model stability. These algorithms included Generalized Linear Models (vglmContRatio, vglmCumulative, bayesglm, glmboost, glm), XGBoost (xgbLinear, xgbTree), Regularization Methods (glmnet), Probabilistic Discriminant Analysis (pda, pda2), Random Forest (rf, RRF, cforest), Decision Trees (C5.0, C5.0Tree), Kernel Methods (kernelpls, pls, simpls, widekernelpls, spls), Neural Networks (nnet, pcaNNet), Recursive Partitioning and Regression Trees (rpart), Conditional Inference Trees (ctree), Support Vector Machines (svmLinear, svmRadial, svmRadialCost, svmRadialSigma), and other ML algorithms (LogitBoost, fda, kknn, knn, lda, lda2, earth, gcvEarth). The optimal model was selected as the SAFE-Mo according to the best AUC in the internal validation set. The primary outcome measure of this study was the prediction of 26-day mortality in patients with sepsis-associated ARDS.</p></sec><sec><title>Model validation and comparison</title><p>To improve the credibility of SAFE-Mo, both internal and external validations were performed. The internal validation set was from MIMIC-IV database. External validation was carried out using two independent datasets: one from the eICU-CRD database and the other from the NWICU database. To evaluate the performance of SAFE-Mo, in internal validation set, we first conducted a systematic assessment of all essential binary classification metrics (accuracy, precision, recall, F1-score, specificity, sensitivity, negative predictive value (NPV), and positive predictive value (PPV)) through bootstrap resampling (R&#160;=&#160;100 iterations) to ensure robust estimation. Subsequently, Wilcoxon analysis, univariate analysis, and multivariate logistic regression were utilized to contrast it with four commonly used clinical risk assessment models (APS III, SAPS II, SOFA, CCI) in external validation set one. External validation set two was used as an independent dataset that more closely reflected real-world clinical scenarios to further validate the clinical applicability of SAFE-Mo. Additionally, Pearson correlation analysis was performed to compare the correlation between SAFE-Mo and the four clinical risk assessment models. A logistic model was established, combining the optimal model with the four clinical risk assessment models.</p><p>Furthermore, the performance of SAFE-Mo and previous clinical risk assessment models were evaluated using three dimensions: discrimination, calibration, and clinical utility. Discrimination was quantitatively assessed using the AUC. Decision Curve Analysis (DCA) curves were drawn using the rmda package<sup>[<xref rid="R25" ref-type="bibr">25</xref>]</sup> in R to further evaluate its clinical application value. Calibration was evaluated through the consistency of predicted probabilities and graphical representations of observed outcomes based on 1000 bootstrap resamples.</p></sec><sec><title>Statistical analysis</title><p>(1) Data extraction and preprocessing platforms. Data from the MIMIC-IV, eICU CRD, and NWICU databases were extracted and integrated using the SQL. SQL scripts were implemented using ProstgreSQL (v17.2, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.postgresql.org/" ext-link-type="uri">https://www.postgresql.org/</ext-link>) and Navicat Premium 16 (Navicat, v16.3.11, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.navicat.com.cn/products/navicat-premium" ext-link-type="uri">https://www.navicat.com.cn/products/navicat-premium</ext-link>). (2) Methods for variable description. Continuous variables were presented as mean&#160;&#177; standard deviation (mean&#160;&#177; SD) if they satisfied the normality assumption by the Shapiro&#8211;Wilk test; otherwise, they were reported as median (interquartile range). Categorical variables were expressed as counts or percentages. (3) Statistical methods for group comparisons. For continuous variables, Student&#8217;s <italic toggle="yes">t</italic>-test was used if the normality assumption was met; otherwise, the Wilcoxon rank-sum test was applied. Categorical variables were analyzed using Pearson&#8217;s chi-squared (<italic toggle="yes">&#967;</italic><xref rid="R2" ref-type="bibr">2</xref>) test, with Fisher&#8217;s exact test employed when any expected cell count was &lt;5. A two-sided <italic toggle="yes">P</italic>-value &lt; 0.05 was considered statistically significant. (4) Statistical software. Statistical analysis and data visualization was performed using R software (Version 4.3.3, The R Project for Statistical Computing, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.r-project.org/" ext-link-type="uri">https://www.r-project.org/</ext-link>). All selections of statistical tests and statistical calculations were performed using the tableone package. All graphics were created with the ggplot2 package.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Baseline data characteristics</title><p>According to the workflow depicted in Figure <xref rid="F1" ref-type="fig">1</xref>, a total of 3451 patients from the MIMIC-IV database were included in this study. Among these participants, 2276 survived, while 1175 did not survive. The median survival time for the deceased cohort was 26&#160;days (Supplemental Digital Content, Fig. S1, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E461" ext-link-type="uri">http://links.lww.com/JS9/E461</ext-link>). Baseline characteristics were analyzed with a focus on 26-day mortality as the primary outcome (Table <xref rid="T1" ref-type="table">1</xref>).
<fig position="float" id="F1" orientation="portrait"><label>Figure 1.</label><caption><p>Workflow diagram. <italic toggle="yes">MIMIC-IV</italic> Medical Information Mart for Intensive Care IV, <italic toggle="yes">eICU-CRD</italic> eICU Collaborative Research Database. <italic toggle="yes">NWICU</italic> Northwest ICU.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6008-g001.jpg"/></fig>
<table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Baseline table</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Death</th><th align="center" rowspan="1" colspan="1">Survival</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number (sample size)</td><td align="center" rowspan="1" colspan="1">1175</td><td align="center" rowspan="1" colspan="1">2276</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Demographic characteristics</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Gender (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Male</td><td align="center" rowspan="1" colspan="1">635&#160;&#177;&#160;54.0</td><td align="center" rowspan="1" colspan="1">1290&#160;&#177;&#160;56.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Female</td><td align="center" rowspan="1" colspan="1">540&#160;&#177;&#160;46.0</td><td align="center" rowspan="1" colspan="1">986&#160;&#177;&#160;43.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Admission type (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Emergency</td><td align="center" rowspan="1" colspan="1">849&#160;&#177;&#160;72.3</td><td align="center" rowspan="1" colspan="1">1683&#160;&#177;&#160;73.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Surgery</td><td align="center" rowspan="1" colspan="1">9&#160;&#177;&#160;0.8</td><td align="center" rowspan="1" colspan="1">65&#160;&#177;&#160;2.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Urgent</td><td align="center" rowspan="1" colspan="1">305&#160;&#177;&#160;26.0</td><td align="center" rowspan="1" colspan="1">502&#160;&#177;&#160;22.1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Elective</td><td align="center" rowspan="1" colspan="1">8&#160;&#177;&#160;0.7</td><td align="center" rowspan="1" colspan="1">24&#160;&#177;&#160;1.1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Observation</td><td align="center" rowspan="1" colspan="1">4&#160;&#177;&#160;0.3</td><td align="center" rowspan="1" colspan="1">2&#160;&#177;&#160;0.1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Insurance (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.027</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Medicare</td><td align="center" rowspan="1" colspan="1">773&#160;&#177;&#160;65.8</td><td align="center" rowspan="1" colspan="1">1378&#160;&#177;&#160;60.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Private</td><td align="center" rowspan="1" colspan="1">242&#160;&#177;&#160;20.6</td><td align="center" rowspan="1" colspan="1">545&#160;&#177;&#160;23.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Medicaid</td><td align="center" rowspan="1" colspan="1">139&#160;&#177;&#160;11.8</td><td align="center" rowspan="1" colspan="1">310&#160;&#177;&#160;13.6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Other</td><td align="center" rowspan="1" colspan="1">21&#160;&#177;&#160;1.8</td><td align="center" rowspan="1" colspan="1">43&#160;&#177;&#160;1.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Marital status (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Married</td><td align="center" rowspan="1" colspan="1">529&#160;&#177;&#160;45.0</td><td align="center" rowspan="1" colspan="1">1056&#160;&#177;&#160;46.4</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Single</td><td align="center" rowspan="1" colspan="1">341&#160;&#177;&#160;29.0</td><td align="center" rowspan="1" colspan="1">744&#160;&#177;&#160;32.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Divorced</td><td align="center" rowspan="1" colspan="1">110&#160;&#177;&#160;9.4</td><td align="center" rowspan="1" colspan="1">194&#160;&#177;&#160;8.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Widowed</td><td align="center" rowspan="1" colspan="1">195&#160;&#177;&#160;16.6</td><td align="center" rowspan="1" colspan="1">282&#160;&#177;&#160;12.4</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Race (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.144</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;White</td><td align="center" rowspan="1" colspan="1">822&#160;&#177;&#160;70.0</td><td align="center" rowspan="1" colspan="1">1652&#160;&#177;&#160;72.6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Black</td><td align="center" rowspan="1" colspan="1">158&#160;&#177;&#160;13.4</td><td align="center" rowspan="1" colspan="1">299&#160;&#177;&#160;13.1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Asian</td><td align="center" rowspan="1" colspan="1">66&#160;&#177;&#160;5.6</td><td align="center" rowspan="1" colspan="1">92&#160;&#177;&#160;4.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Other</td><td align="center" rowspan="1" colspan="1">129&#160;&#177;&#160;11.0</td><td align="center" rowspan="1" colspan="1">233&#160;&#177;&#160;10.2</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Vital signs</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Age (year, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">70.99&#160;&#177;&#160;14.37</td><td align="center" rowspan="1" colspan="1">67.04&#160;&#177;&#160;15.56</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Heart rate min (times/minute, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">76.60&#160;&#177;&#160;17.60</td><td align="center" rowspan="1" colspan="1">77.20&#160;&#177;&#160;15.97</td><td align="center" rowspan="1" colspan="1">0.312</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Heart rate max (times/minute, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">114.30&#160;&#177;&#160;22.44</td><td align="center" rowspan="1" colspan="1">112.43&#160;&#177;&#160;21.02</td><td align="center" rowspan="1" colspan="1">0.015</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;SBP min (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">77.47&#160;&#177;&#160;14.41</td><td align="center" rowspan="1" colspan="1">84.66&#160;&#177;&#160;12.96</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;SBP max (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">139.55&#160;&#177;&#160;20.65</td><td align="center" rowspan="1" colspan="1">144.55&#160;&#177;&#160;20.38</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;DBP min (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">38.64&#160;&#177;&#160;10.08</td><td align="center" rowspan="1" colspan="1">42.59&#160;&#177;&#160;9.30</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;DBP max (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">84.04&#160;&#177;&#160;18.29</td><td align="center" rowspan="1" colspan="1">86.01&#160;&#177;&#160;17.65</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;MBP min (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">49.10&#160;&#177;&#160;11.35</td><td align="center" rowspan="1" colspan="1">54.37&#160;&#177;&#160;9.99</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;MBP max (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">97.95&#160;&#177;&#160;17.80</td><td align="center" rowspan="1" colspan="1">100.56&#160;&#177;&#160;17.20</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Respiratory rate min (times/minute, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">13.57&#160;&#177;&#160;4.20</td><td align="center" rowspan="1" colspan="1">13.35&#160;&#177;&#160;3.81</td><td align="center" rowspan="1" colspan="1">0.115</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Respiratory rate max (times/minute, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">30.58&#160;&#177;&#160;6.04</td><td align="center" rowspan="1" colspan="1">29.65&#160;&#177;&#160;6.13</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Temperature min (&#176;C, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">36.16&#160;&#177;&#160;0.67</td><td align="center" rowspan="1" colspan="1">36.37&#160;&#177;&#160;0.59</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Temperature max (&#176;C, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">37.44&#160;&#177;&#160;0.91</td><td align="center" rowspan="1" colspan="1">37.76&#160;&#177;&#160;0.90</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Laboratory tests</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;SPO<sub>2</sub> min (%, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">90.65&#160;&#177;&#160;4.44</td><td align="center" rowspan="1" colspan="1">91.93&#160;&#177;&#160;4.02</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Urine output (mL, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">1262.56&#160;&#177;&#160;1313.86</td><td align="center" rowspan="1" colspan="1">2023.21&#160;&#177;&#160;1411.44</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Lactate min (mmol/l, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">2.20&#160;&#177;&#160;1.01</td><td align="center" rowspan="1" colspan="1">1.57&#160;&#177;&#160;0.80</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Lactate max (mmol/l, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">4.04&#160;&#177;&#160;2.46</td><td align="center" rowspan="1" colspan="1">2.55&#160;&#177;&#160;1.89</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;pH min (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">7.24&#160;&#177;&#160;0.14</td><td align="center" rowspan="1" colspan="1">7.30&#160;&#177;&#160;0.11</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;pH max (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">7.38&#160;&#177;&#160;0.09</td><td align="center" rowspan="1" colspan="1">7.40&#160;&#177;&#160;0.07</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;PO<sub>2</sub> min (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">61.37&#160;&#177;&#160;27.67</td><td align="center" rowspan="1" colspan="1">69.62&#160;&#177;&#160;29.71</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;PO<sub>2</sub> max (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">179.39&#160;&#177;&#160;109.91</td><td align="center" rowspan="1" colspan="1">177.59&#160;&#177;&#160;109.01</td><td align="center" rowspan="1" colspan="1">0.647</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;PCO<sub>2</sub> min (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">34.56&#160;&#177;&#160;9.04</td><td align="center" rowspan="1" colspan="1">35.68&#160;&#177;&#160;8.19</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;PCO<sub>2</sub> max (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">48.85&#160;&#177;&#160;13.80</td><td align="center" rowspan="1" colspan="1">47.61&#160;&#177;&#160;13.17</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;A-aDO<sub>2</sub>-Calc min (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">217.24&#160;&#177;&#160;115.99</td><td align="center" rowspan="1" colspan="1">181.24&#160;&#177;&#160;103.59</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;A-aDO<sub>2</sub>-Calc max (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">404.64&#160;&#177;&#160;172.19</td><td align="center" rowspan="1" colspan="1">337.91&#160;&#177;&#160;170.48</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Base excess min (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">&#8722;7.82&#160;&#177;&#160;7.44</td><td align="center" rowspan="1" colspan="1">&#8722;4.35&#160;&#177;&#160;5.85</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Base excess max (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">&#8722;2.21&#160;&#177;&#160;5.26</td><td align="center" rowspan="1" colspan="1">&#8722;0.49&#160;&#177;&#160;4.24</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Total CO<sub>2</sub> min (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">19.23&#160;&#177;&#160;6.57</td><td align="center" rowspan="1" colspan="1">21.77&#160;&#177;&#160;5.72</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Total CO<sub>2</sub> max (mmHg, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">24.25&#160;&#177;&#160;5.98</td><td align="center" rowspan="1" colspan="1">25.66&#160;&#177;&#160;5.18</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Platelets min (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">166.61&#160;&#177;&#160;109.45</td><td align="center" rowspan="1" colspan="1">191.60&#160;&#177;&#160;106.60</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Platelets max (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">214.02&#160;&#177;&#160;126.27</td><td align="center" rowspan="1" colspan="1">236.69&#160;&#177;&#160;123.67</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;WBC min (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">11.90&#160;&#177;&#160;7.14</td><td align="center" rowspan="1" colspan="1">11.18&#160;&#177;&#160;6.25</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;WBC max (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">16.50&#160;&#177;&#160;8.92</td><td align="center" rowspan="1" colspan="1">15.72&#160;&#177;&#160;8.11</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Anion gap min (mmol/l, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">15.09&#160;&#177;&#160;3.89</td><td align="center" rowspan="1" colspan="1">13.16&#160;&#177;&#160;3.20</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Anion gap max (mmol/l, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">19.58&#160;&#177;&#160;4.95</td><td align="center" rowspan="1" colspan="1">17.16&#160;&#177;&#160;4.35</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;BUN min (mg/dL, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">36.02&#160;&#177;&#160;19.73</td><td align="center" rowspan="1" colspan="1">27.84&#160;&#177;&#160;17.95</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;BUN max (mg/dL, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">42.20&#160;&#177;&#160;21.94</td><td align="center" rowspan="1" colspan="1">33.76&#160;&#177;&#160;20.81</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Creatinine min (mg/dL, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">1.70&#160;&#177;&#160;0.97</td><td align="center" rowspan="1" colspan="1">1.35&#160;&#177;&#160;0.86</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Creatinine max (mg/dL, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">2.10&#160;&#177;&#160;1.15</td><td align="center" rowspan="1" colspan="1">1.69&#160;&#177;&#160;1.05</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Abs basophils min (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">0.01&#160;&#177;&#160;0.02</td><td align="center" rowspan="1" colspan="1">0.02&#160;&#177;&#160;0.02</td><td align="center" rowspan="1" colspan="1">0.069</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Abs basophils max (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">0.02&#160;&#177;&#160;0.03</td><td align="center" rowspan="1" colspan="1">0.02&#160;&#177;&#160;0.03</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Abs eosinophils min (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">0.03&#160;&#177;&#160;0.05</td><td align="center" rowspan="1" colspan="1">0.04&#160;&#177;&#160;0.05</td><td align="center" rowspan="1" colspan="1">0.034</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Abs eosinophils max (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">0.05&#160;&#177;&#160;0.07</td><td align="center" rowspan="1" colspan="1">0.06&#160;&#177;&#160;0.07</td><td align="center" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Abs lymphocytes min (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">0.88&#160;&#177;&#160;0.60</td><td align="center" rowspan="1" colspan="1">0.88&#160;&#177;&#160;0.58</td><td align="center" rowspan="1" colspan="1">0.922</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Abs lymphocytes max (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">1.05&#160;&#177;&#160;0.67</td><td align="center" rowspan="1" colspan="1">1.06&#160;&#177;&#160;0.64</td><td align="center" rowspan="1" colspan="1">0.678</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Abs monocytes min (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">0.49&#160;&#177;&#160;0.35</td><td align="center" rowspan="1" colspan="1">0.48&#160;&#177;&#160;0.33</td><td align="center" rowspan="1" colspan="1">0.446</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Abs monocytes max (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">0.60&#160;&#177;&#160;0.41</td><td align="center" rowspan="1" colspan="1">0.60&#160;&#177;&#160;0.38</td><td align="center" rowspan="1" colspan="1">0.677</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Abs neutrophils min (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">11.01&#160;&#177;&#160;7.08</td><td align="center" rowspan="1" colspan="1">10.51&#160;&#177;&#160;6.25</td><td align="center" rowspan="1" colspan="1">0.032</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Abs neutrophils max (1&#160;&#215;&#160;10<sup>9</sup>/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">12.26&#160;&#177;&#160;7.64</td><td align="center" rowspan="1" colspan="1">12.07&#160;&#177;&#160;7.05</td><td align="center" rowspan="1" colspan="1">0.471</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;INR min (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">1.48&#160;&#177;&#160;0.37</td><td align="center" rowspan="1" colspan="1">1.36&#160;&#177;&#160;0.30</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;INR max (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">1.83&#160;&#177;&#160;0.65</td><td align="center" rowspan="1" colspan="1">1.55&#160;&#177;&#160;0.50</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Pt min (seconds, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">16.17&#160;&#177;&#160;3.82</td><td align="center" rowspan="1" colspan="1">14.96&#160;&#177;&#160;3.10</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Pt max (seconds, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">19.47&#160;&#177;&#160;6.20</td><td align="center" rowspan="1" colspan="1">16.78&#160;&#177;&#160;4.80</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Ptt min (seconds, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">35.40&#160;&#177;&#160;8.37</td><td align="center" rowspan="1" colspan="1">32.40&#160;&#177;&#160;7.00</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Ptt max (seconds, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">44.99&#160;&#177;&#160;15.65</td><td align="center" rowspan="1" colspan="1">38.56&#160;&#177;&#160;12.97</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;ALT min (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">39.65&#160;&#177;&#160;31.07</td><td align="center" rowspan="1" colspan="1">37.03&#160;&#177;&#160;28.83</td><td align="center" rowspan="1" colspan="1">0.014</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;ALT max (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">48.99&#160;&#177;&#160;39.77</td><td align="center" rowspan="1" colspan="1">43.55&#160;&#177;&#160;36.26</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;ALP min (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">102.19&#160;&#177;&#160;52.55</td><td align="center" rowspan="1" colspan="1">98.47&#160;&#177;&#160;50.82</td><td align="center" rowspan="1" colspan="1">0.044</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;ALP max (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">115.87&#160;&#177;&#160;60.24</td><td align="center" rowspan="1" colspan="1">108.10&#160;&#177;&#160;57.93</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;AST min (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">65.58&#160;&#177;&#160;46.25</td><td align="center" rowspan="1" colspan="1">52.27&#160;&#177;&#160;41.15</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;AST max (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">84.99&#160;&#177;&#160;65.89</td><td align="center" rowspan="1" colspan="1">64.98&#160;&#177;&#160;57.39</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Total bilirubin min (mg/dL, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">1.14&#160;&#177;&#160;0.92</td><td align="center" rowspan="1" colspan="1">0.94&#160;&#177;&#160;0.84</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Total bilirubin max (mg/dL, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">1.42&#160;&#177;&#160;1.19</td><td align="center" rowspan="1" colspan="1">1.15&#160;&#177;&#160;1.08</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hematocrit min (%, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">29.15&#160;&#177;&#160;5.99</td><td align="center" rowspan="1" colspan="1">29.40&#160;&#177;&#160;5.74</td><td align="center" rowspan="1" colspan="1">0.228</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hematocrit max (%, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">34.08&#160;&#177;&#160;6.11</td><td align="center" rowspan="1" colspan="1">33.78&#160;&#177;&#160;5.96</td><td align="center" rowspan="1" colspan="1">0.172</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Bicarbonate min (mmol/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">18.14&#160;&#177;&#160;5.85</td><td align="center" rowspan="1" colspan="1">20.53&#160;&#177;&#160;5.05</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Bicarbonate max (mmol/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">22.18&#160;&#177;&#160;5.21</td><td align="center" rowspan="1" colspan="1">23.92&#160;&#177;&#160;4.46</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Glucose min (mg/dL, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">107.78&#160;&#177;&#160;37.67</td><td align="center" rowspan="1" colspan="1">112.29&#160;&#177;&#160;32.01</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Glucose max (mg/dL, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">171.57&#160;&#177;&#160;66.59</td><td align="center" rowspan="1" colspan="1">165.74&#160;&#177;&#160;60.42</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hemoglobin min (g/dL, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">9.44&#160;&#177;&#160;1.96</td><td align="center" rowspan="1" colspan="1">9.67&#160;&#177;&#160;1.93</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hemoglobin max (g/dL, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">10.98&#160;&#177;&#160;2.02</td><td align="center" rowspan="1" colspan="1">11.04&#160;&#177;&#160;2.01</td><td align="center" rowspan="1" colspan="1">0.387</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Calcium min (mmol/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">7.60&#160;&#177;&#160;0.88</td><td align="center" rowspan="1" colspan="1">7.67&#160;&#177;&#160;0.79</td><td align="center" rowspan="1" colspan="1">0.027</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Calcium max (mmol/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">8.35&#160;&#177;&#160;0.82</td><td align="center" rowspan="1" colspan="1">8.30&#160;&#177;&#160;0.73</td><td align="center" rowspan="1" colspan="1">0.053</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Potassium min (mmol/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">3.98&#160;&#177;&#160;0.67</td><td align="center" rowspan="1" colspan="1">3.80&#160;&#177;&#160;0.60</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Potassium max (mmol/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">4.75&#160;&#177;&#160;0.76</td><td align="center" rowspan="1" colspan="1">4.52&#160;&#177;&#160;0.73</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Sodium min (mmol/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">136.06&#160;&#177;&#160;5.70</td><td align="center" rowspan="1" colspan="1">136.23&#160;&#177;&#160;4.83</td><td align="center" rowspan="1" colspan="1">0.338</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Sodium max (mmol/L, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">139.61&#160;&#177;&#160;5.67</td><td align="center" rowspan="1" colspan="1">139.47&#160;&#177;&#160;4.66</td><td align="center" rowspan="1" colspan="1">0.456</td></tr><tr><td align="left" rowspan="1" colspan="1">Comorbidities</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial infarct (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">959&#160;&#177;&#160;81.6</td><td align="center" rowspan="1" colspan="1">1952&#160;&#177;&#160;85.8</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">216&#160;&#177;&#160;18.4</td><td align="center" rowspan="1" colspan="1">324&#160;&#177;&#160;14.2</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Congestive heart failure (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.112</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">739&#160;&#177;&#160;62.9</td><td align="center" rowspan="1" colspan="1">1495&#160;&#177;&#160;65.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">436&#160;&#177;&#160;37.1</td><td align="center" rowspan="1" colspan="1">781&#160;&#177;&#160;34.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Peripheral vascular disease (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.056</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">1013&#160;&#177;&#160;86.2</td><td align="center" rowspan="1" colspan="1">2015&#160;&#177;&#160;88.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">162&#160;&#177;&#160;13.8</td><td align="center" rowspan="1" colspan="1">261&#160;&#177;&#160;11.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cerebrovascular disease (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.277</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">1036&#160;&#177;&#160;88.2</td><td align="center" rowspan="1" colspan="1">2036&#160;&#177;&#160;89.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">139&#160;&#177;&#160;11.8</td><td align="center" rowspan="1" colspan="1">240&#160;&#177;&#160;10.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Dementia (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.086</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">1137&#160;&#177;&#160;96.8</td><td align="center" rowspan="1" colspan="1">2226&#160;&#177;&#160;97.8</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">38&#160;&#177;&#160;3.2</td><td align="center" rowspan="1" colspan="1">50&#160;&#177;&#160;2.2</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Chronic pulmonary disease (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.283</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">795&#160;&#177;&#160;67.7</td><td align="center" rowspan="1" colspan="1">1582&#160;&#177;&#160;69.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">380&#160;&#177;&#160;32.3</td><td align="center" rowspan="1" colspan="1">694&#160;&#177;&#160;30.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Rheumatic disease (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.499</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">1121&#160;&#177;&#160;95.4</td><td align="center" rowspan="1" colspan="1">2184&#160;&#177;&#160;96.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">54&#160;&#177;&#160;4.6</td><td align="center" rowspan="1" colspan="1">92&#160;&#177;&#160;4.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Peptic ulcer disease (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.843</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">1137&#160;&#177;&#160;96.8</td><td align="center" rowspan="1" colspan="1">2198&#160;&#177;&#160;96.6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">38&#160;&#177;&#160;3.2</td><td align="center" rowspan="1" colspan="1">78&#160;&#177;&#160;3.4</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mild liver disease (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">782&#160;&#177;&#160;66.6</td><td align="center" rowspan="1" colspan="1">1818&#160;&#177;&#160;79.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">393&#160;&#177;&#160;33.4</td><td align="center" rowspan="1" colspan="1">458&#160;&#177;&#160;20.1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes without CC (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.677</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">851&#160;&#177;&#160;72.4</td><td align="center" rowspan="1" colspan="1">1665&#160;&#177;&#160;73.2</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">324&#160;&#177;&#160;27.6</td><td align="center" rowspan="1" colspan="1">611&#160;&#177;&#160;26.8</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes with CC (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.104</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">1089&#160;&#177;&#160;92.7</td><td align="center" rowspan="1" colspan="1">2071&#160;&#177;&#160;91.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">86&#160;&#177;&#160;7.3</td><td align="center" rowspan="1" colspan="1">205&#160;&#177;&#160;9.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Paraplegia (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">1140&#160;&#177;&#160;97.0</td><td align="center" rowspan="1" colspan="1">2174&#160;&#177;&#160;95.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">35&#160;&#177;&#160;3.0</td><td align="center" rowspan="1" colspan="1">102&#160;&#177;&#160;4.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Renal disease (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">830&#160;&#177;&#160;70.6</td><td align="center" rowspan="1" colspan="1">1703&#160;&#177;&#160;74.8</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">345&#160;&#177;&#160;29.4</td><td align="center" rowspan="1" colspan="1">573&#160;&#177;&#160;25.2</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Malignant cancer (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">927&#160;&#177;&#160;78.9</td><td align="center" rowspan="1" colspan="1">1947&#160;&#177;&#160;85.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">248&#160;&#177;&#160;21.1</td><td align="center" rowspan="1" colspan="1">329&#160;&#177;&#160;14.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Severe liver disease (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">1004&#160;&#177;&#160;85.4</td><td align="center" rowspan="1" colspan="1">2121&#160;&#177;&#160;93.2</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">171&#160;&#177;&#160;14.6</td><td align="center" rowspan="1" colspan="1">155&#160;&#177;&#160;6.8</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Metastatic solid tumor (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">1011&#160;&#177;&#160;86.0</td><td align="center" rowspan="1" colspan="1">2155&#160;&#177;&#160;94.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">164&#160;&#177;&#160;14.0</td><td align="center" rowspan="1" colspan="1">121&#160;&#177;&#160;5.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">AIDS (<italic toggle="yes">n</italic>, mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;No</td><td align="center" rowspan="1" colspan="1">1172&#160;&#177;&#160;99.7</td><td align="center" rowspan="1" colspan="1">2245&#160;&#177;&#160;98.6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Yes</td><td align="center" rowspan="1" colspan="1">3&#160;&#177;&#160;0.3</td><td align="center" rowspan="1" colspan="1">31&#160;&#177;&#160;1.4</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Clinical risk assessment models</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;APSIII (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">78.76&#160;&#177;&#160;26.89</td><td align="center" rowspan="1" colspan="1">58.20&#160;&#177;&#160;22.28</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;SAPSII (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">56.47&#160;&#177;&#160;16.26</td><td align="center" rowspan="1" colspan="1">42.90&#160;&#177;&#160;14.64</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;SOFA-24&#160;hours (mean&#160;&#177;&#160;SD)</td><td align="center" rowspan="1" colspan="1">2.86 (2.87)</td><td align="center" rowspan="1" colspan="1">1.38 (1.58)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;CCI (mean&#160;&#177; SD)</td><td align="center" rowspan="1" colspan="1">6.61&#160;&#177;&#160;2.79</td><td align="center" rowspan="1" colspan="1">5.14&#160;&#177;&#160;2.82</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn id="tbl1-fn1"><p>A-aDO<sub>2</sub>&#8212;calc, Arterial-Alveolar Oxygen Difference Calculation; Abs, Absolute; AIDS, Acquired Immunodeficiency Syndrome; ALP, Alkaline Phosphatase; ALT, Alanine Aminotransferase; AST, Aspartate Aminotransferase; APSIII, Acute Physiology Score III; BUN, Blood Urea Nitrogen; CC, Chronic Complication; CCI, Charlson Comorbidity Index; DBP, Diastolic Blood Pressure; INR, International Normalized Ratio; max, Maximum, MBP, Mean Blood Pressure; min, Minimum; n, number; Pt, Prothrombin Time; Ptt, Partial Thromboplastin Time; SAPSII, Simplified Acute Physiology Score II; SBP, Systolic Blood Pressure; SD, Standard Deviation; SOFA, sequential organ failure assessment; SpO<sub>2</sub>, Oxygen Saturation.</p></fn></table-wrap-foot></table-wrap>
</p><p>The optimal MI algorithm was rf, which was selected based on the degree of overlap between the true values and the imputed values (Supplemental Digital Content, Fig. S2, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E461" ext-link-type="uri">http://links.lww.com/JS9/E461</ext-link>). This process was repeated 50 times, and the mean value was taken to impute the missing data for further analysis.</p></sec><sec><title>Algorithm and variables analysis</title><p>Initially, Lasso regression analysis was performed to refine the selection of predictive variables. First, Lasso coefficient analysis was conducted on the variables (Fig. <xref rid="F2" ref-type="fig">2</xref>A), followed by ten-fold cross-validation to determine the optimal lambda value (lambda.min&#160;=&#160;0.0135). This resulted in a model that included 32 variables and demonstrated superior performance (Fig. <xref rid="F2" ref-type="fig">2</xref>B). Additionally, the kappa value (also known as the condition number, reflecting multicollinearity [visualized in Supplemental Digital Content, Fig. S3 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E461" ext-link-type="uri">http://links.lww.com/JS9/E461</ext-link>]) of the design matrix decreased from 985.0592 to 59.1384 after Lasso analysis, indicating a significant reduction in multicollinearity among the selected variables. The mean AUC for each algorithm model was evaluated using ten-fold cross-validation (Fig. <xref rid="F2" ref-type="fig">2</xref>C).
<fig position="float" id="F2" orientation="portrait"><label>Figure 2.</label><caption><p>Identification and screening of model variables and algorithms for predicting 26-day mortality. (A) The lasso coefficient analysis. <italic toggle="yes">Log(lambda)</italic>: Log Regularization Parameter, X axis represented the log of the regularization parameter lambda. <italic toggle="yes">Coefficients</italic>: Y axis showed the feature coefficients of the variables in the model. These coefficients reflected the degree to which each feature affects the model&#8217;s predictions. Each line represented a different variable, and the value of the feature coefficient for each variable is plotted against the Log(lambda). The dotted line represented the corresponding feature coefficient of each variable under the optimal lambda value. (B) The relationship between partial likelihood deviance and the regularization parameter lambda in the lasso model. <italic toggle="yes">Log(lambda)</italic>: Log Regularization Parameter, X axis represented the log of the regularization parameter <italic toggle="yes">lambda. Partial Likelihood Deviance</italic>: Y axis showed the partial likelihood deviance for different values of the regularization parameter. Partial likelihood deviance quantifies model fit (lower values indicate better predictive performance). Dots represented the average partial likelihood deviance with the standard deviation of the partial likelihood deviance. The dotted line indicated the minimum lambda by ten-fold cross-validation. (C) Average AUC values for multiple ML algorithms. <italic toggle="yes">AUC</italic> area under the curve.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6008-g002.jpg"/></fig>
</p><p>The AUC of ML algorithm models were calculated using the training set, alongside accuracy, precision, recall, F1-score, specificity, sensitivity, NPV, and PPV for comprehensive model diagnostics. Based on these evaluations, the SVM with radial basis function kernel and sigma optimization (svmRadialSigma) was selected as the optimal algorithm, designated as the only algorithm of SAFE-Mo (Supplemental Digital Content, Table <xref rid="T2" ref-type="table">2</xref>, Table S5 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E466" ext-link-type="uri">http://links.lww.com/JS9/E466</ext-link>, and Figure <xref rid="F3" ref-type="fig">3</xref>).Variable importance analysis within SAFE-Mo identified the ranking of variables. Variables with an importance score exceeding 65 included lactate max, lactate min, urine output, and anion gap min (Fig. <xref rid="F4" ref-type="fig">4</xref>A).
<fig position="float" id="F3" orientation="portrait"><label>Figure 3.</label><caption><p>ROC curves of each ML algorithm for predicting 26-day mortality using trial set. <italic toggle="yes">ROC</italic> Receiver Operating Characteristic, <italic toggle="yes">AUC</italic> Area Under the Curve. The red curve highlighted the best ML algorithms, and the rest of the algorithms were represented by gray curves.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6008-g003.jpg"/></fig>
<fig position="float" id="F4" orientation="portrait"><label>Figure 4.</label><caption><p>Variable importance analysis and discrimination verification of SAFE-Mo. (A) Visualization of variable importance. (B) Confusion matrix and discrimination metrics in internal validation (C) Confusion matrix and discrimination metrics in external validation set one. (D) Confusion matrix and discrimination metrics in external validation set two.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6008-g004.jpg"/></fig>
<table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><p>Evaluation of each ML algorithm</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Method</th><th align="center" rowspan="1" colspan="1">Accuracy</th><th align="center" rowspan="1" colspan="1">Precision</th><th align="center" rowspan="1" colspan="1">Recall</th><th align="center" rowspan="1" colspan="1">F1-score</th><th align="center" rowspan="1" colspan="1">Specificity</th><th align="center" rowspan="1" colspan="1">Sensitivity</th><th align="center" rowspan="1" colspan="1">NPV</th><th align="center" rowspan="1" colspan="1">PPV</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">svmRadialSigma</td><td align="left" rowspan="1" colspan="1">0.75 (0.72-0.78)</td><td align="left" rowspan="1" colspan="1">0.61 (0.51-0.68)</td><td align="left" rowspan="1" colspan="1">0.72 (0.64-0.86)</td><td align="left" rowspan="1" colspan="1">0.66 (0.62-0.71)</td><td align="left" rowspan="1" colspan="1">0.77 (0.64-0.83)</td><td align="left" rowspan="1" colspan="1">0.72 (0.64-0.86)</td><td align="left" rowspan="1" colspan="1">0.85 (0.81-0.91)</td><td align="left" rowspan="1" colspan="1">0.61 (0.51-0.68)</td></tr><tr><td align="left" rowspan="1" colspan="1">glm</td><td align="left" rowspan="1" colspan="1">0.74 (0.71-0.78)</td><td align="left" rowspan="1" colspan="1">0.60 (0.51-0.73)</td><td align="left" rowspan="1" colspan="1">0.71 (0.57-0.87)</td><td align="left" rowspan="1" colspan="1">0.65 (0.60-0.70)</td><td align="left" rowspan="1" colspan="1">0.76 (0.61-0.89)</td><td align="left" rowspan="1" colspan="1">0.71 (0.57-0.87)</td><td align="left" rowspan="1" colspan="1">0.84 (0.80-0.90)</td><td align="left" rowspan="1" colspan="1">0.60 (0.51-0.73)</td></tr><tr><td align="left" rowspan="1" colspan="1">glmnet</td><td align="left" rowspan="1" colspan="1">0.74 (0.71-0.78)</td><td align="left" rowspan="1" colspan="1">0.60 (0.54-0.69)</td><td align="left" rowspan="1" colspan="1">0.72 (0.63-0.81)</td><td align="left" rowspan="1" colspan="1">0.66 (0.61-0.70)</td><td align="left" rowspan="1" colspan="1">0.76 (0.67-0.85)</td><td align="left" rowspan="1" colspan="1">0.72 (0.63-0.81)</td><td align="left" rowspan="1" colspan="1">0.85 (0.81-0.89)</td><td align="left" rowspan="1" colspan="1">0.60 (0.54-0.69)</td></tr><tr><td align="left" rowspan="1" colspan="1">lda</td><td align="left" rowspan="1" colspan="1">0.74 (0.71-0.78)</td><td align="left" rowspan="1" colspan="1">0.60 (0.52-0.71)</td><td align="left" rowspan="1" colspan="1">0.73 (0.61-0.82)</td><td align="left" rowspan="1" colspan="1">0.66 (0.60-0.71)</td><td align="left" rowspan="1" colspan="1">0.75 (0.65-0.86)</td><td align="left" rowspan="1" colspan="1">0.73 (0.61-0.82)</td><td align="left" rowspan="1" colspan="1">0.85 (0.81-0.89)</td><td align="left" rowspan="1" colspan="1">0.60 (0.52-0.71)</td></tr><tr><td align="left" rowspan="1" colspan="1">pcaNNet</td><td align="left" rowspan="1" colspan="1">0.74 (0.71-0.78)</td><td align="left" rowspan="1" colspan="1">0.60 (0.54-0.67)</td><td align="left" rowspan="1" colspan="1">0.73 (0.65-0.79)</td><td align="left" rowspan="1" colspan="1">0.66 (0.61-0.70)</td><td align="left" rowspan="1" colspan="1">0.75 (0.72-0.83)</td><td align="left" rowspan="1" colspan="1">0.73 (0.65-0.79)</td><td align="left" rowspan="1" colspan="1">0.85 (0.81-0.89)</td><td align="left" rowspan="1" colspan="1">0.60 (0.54-0.67)</td></tr><tr><td align="left" rowspan="1" colspan="1">spls</td><td align="left" rowspan="1" colspan="1">0.74 (0.70-0.78)</td><td align="left" rowspan="1" colspan="1">0.63 (0.52-0.70)</td><td align="left" rowspan="1" colspan="1">0.68 (0.58-0.83)</td><td align="left" rowspan="1" colspan="1">0.65 (0.60-0.70)</td><td align="left" rowspan="1" colspan="1">0.80 (0.63-0.86)</td><td align="left" rowspan="1" colspan="1">0.68 (0.58-0.83)</td><td align="left" rowspan="1" colspan="1">0.83 (0.80-0.88)</td><td align="left" rowspan="1" colspan="1">0.63 (0.52-0.70)</td></tr><tr><td align="left" rowspan="1" colspan="1">svmLinear</td><td align="left" rowspan="1" colspan="1">0.74 (0.71-0.78)</td><td align="left" rowspan="1" colspan="1">0.58 (0.51-0.72)</td><td align="left" rowspan="1" colspan="1">0.74 (0.57-0.85)</td><td align="left" rowspan="1" colspan="1">0.65 (0.62-0.70)</td><td align="left" rowspan="1" colspan="1">0.73 (0.65-0.90)</td><td align="left" rowspan="1" colspan="1">0.74 (0.57-0.85)</td><td align="left" rowspan="1" colspan="1">0.85 (0.81-0.90)</td><td align="left" rowspan="1" colspan="1">0.58 (0.51-0.72)</td></tr><tr><td align="left" rowspan="1" colspan="1">svmRadial</td><td align="left" rowspan="1" colspan="1">0.74 (0.71-0.78)</td><td align="left" rowspan="1" colspan="1">0.59 (0.53-0.68)</td><td align="left" rowspan="1" colspan="1">0.73 (0.65-0.82)</td><td align="left" rowspan="1" colspan="1">0.65 (0.61-0.71)</td><td align="left" rowspan="1" colspan="1">0.75 (0.66-0.86)</td><td align="left" rowspan="1" colspan="1">0.73 (0.65-0.82)</td><td align="left" rowspan="1" colspan="1">0.85 (0.81-0.90)</td><td align="left" rowspan="1" colspan="1">0.59 (0.53-0.68)</td></tr><tr><td align="left" rowspan="1" colspan="1">svmRadialCost</td><td align="left" rowspan="1" colspan="1">0.74 (0.72-0.78)</td><td align="left" rowspan="1" colspan="1">0.58 (0.52-0.71)</td><td align="left" rowspan="1" colspan="1">0.76 (0.62-0.84)</td><td align="left" rowspan="1" colspan="1">0.66 (0.62-0.71)</td><td align="left" rowspan="1" colspan="1">0.72 (0.65-0.87)</td><td align="left" rowspan="1" colspan="1">0.76 (0.62-0.84)</td><td align="left" rowspan="1" colspan="1">0.86 (0.81-0.90)</td><td align="left" rowspan="1" colspan="1">0.58 (0.52-0.71)</td></tr><tr><td align="left" rowspan="1" colspan="1">vglmContRatio</td><td align="left" rowspan="1" colspan="1">0.74 (0.70-0.78)</td><td align="left" rowspan="1" colspan="1">0.61 (0.51-0.71)</td><td align="left" rowspan="1" colspan="1">0.72 (0.61-0.83)</td><td align="left" rowspan="1" colspan="1">0.66 (0.60-0.70)</td><td align="left" rowspan="1" colspan="1">0.77 (0.64-0.87)</td><td align="left" rowspan="1" colspan="1">0.72 (0.61-0.83)</td><td align="left" rowspan="1" colspan="1">0.84 (0.81-0.89)</td><td align="left" rowspan="1" colspan="1">0.61 (0.51-0.71)</td></tr><tr><td align="left" rowspan="1" colspan="1">vglmCumulative</td><td align="left" rowspan="1" colspan="1">0.74 (0.71-0.78)</td><td align="left" rowspan="1" colspan="1">0.63 (0.50-0.73)</td><td align="left" rowspan="1" colspan="1">0.66 (0.59-0.86)</td><td align="left" rowspan="1" colspan="1">0.65 (0.61-0.70)</td><td align="left" rowspan="1" colspan="1">0.81 (0.62-0.88)</td><td align="left" rowspan="1" colspan="1">0.66 (0.59-0.86)</td><td align="left" rowspan="1" colspan="1">0.83 (0.80-0.91)</td><td align="left" rowspan="1" colspan="1">0.63 (0.50-0.73)</td></tr><tr><td align="left" rowspan="1" colspan="1">xgbTree</td><td align="left" rowspan="1" colspan="1">0.74 (0.71-0.78)</td><td align="left" rowspan="1" colspan="1">0.61 (0.50-0.73)</td><td align="left" rowspan="1" colspan="1">0.70 (0.58-0.84)</td><td align="left" rowspan="1" colspan="1">0.65 (0.61-0.70)</td><td align="left" rowspan="1" colspan="1">0.78 (0.61-0.89)</td><td align="left" rowspan="1" colspan="1">0.70 (0.58-0.84)</td><td align="left" rowspan="1" colspan="1">0.84 (0.80-0.88)</td><td align="left" rowspan="1" colspan="1">0.61 (0.50-0.73)</td></tr><tr><td align="left" rowspan="1" colspan="1">bayesglm</td><td align="left" rowspan="1" colspan="1">0.73 (0.71-0.77)</td><td align="left" rowspan="1" colspan="1">0.60 (0.50-0.73)</td><td align="left" rowspan="1" colspan="1">0.69 (0.59-0.84)</td><td align="left" rowspan="1" colspan="1">0.65 (0.60-0.70)</td><td align="left" rowspan="1" colspan="1">0.77 (0.62-0.89)</td><td align="left" rowspan="1" colspan="1">0.69 (0.59-0.84)</td><td align="left" rowspan="1" colspan="1">0.83 (0.80-0.90)</td><td align="left" rowspan="1" colspan="1">0.60 (0.50-0.73)</td></tr><tr><td align="left" rowspan="1" colspan="1">glmboost</td><td align="left" rowspan="1" colspan="1">0.73 (0.70-0.77)</td><td align="left" rowspan="1" colspan="1">0.64 (0.53-0.71)</td><td align="left" rowspan="1" colspan="1">0.65 (0.60-0.81)</td><td align="left" rowspan="1" colspan="1">0.65 (0.60-0.69)</td><td align="left" rowspan="1" colspan="1">0.82 (0.64-0.87)</td><td align="left" rowspan="1" colspan="1">0.65 (0.60-0.81)</td><td align="left" rowspan="1" colspan="1">0.82 (0.80-0.88)</td><td align="left" rowspan="1" colspan="1">0.64 (0.53-0.71)</td></tr><tr><td align="left" rowspan="1" colspan="1">lda2</td><td align="left" rowspan="1" colspan="1">0.73 (0.71-0.78)</td><td align="left" rowspan="1" colspan="1">0.65 (0.50-0.70)</td><td align="left" rowspan="1" colspan="1">0.65 (0.59-0.84)</td><td align="left" rowspan="1" colspan="1">0.65 (0.60-0.70)</td><td align="left" rowspan="1" colspan="1">0.82 (0.63-0.85)</td><td align="left" rowspan="1" colspan="1">0.65 (0.59-0.84)</td><td align="left" rowspan="1" colspan="1">0.82 (0.81-0.89)</td><td align="left" rowspan="1" colspan="1">0.65 (0.50-0.70)</td></tr><tr><td align="left" rowspan="1" colspan="1">pda</td><td align="left" rowspan="1" colspan="1">0.73 (0.70-0.77)</td><td align="left" rowspan="1" colspan="1">0.57 (0.52-0.75)</td><td align="left" rowspan="1" colspan="1">0.74 (0.57-0.82)</td><td align="left" rowspan="1" colspan="1">0.65 (0.60-0.70)</td><td align="left" rowspan="1" colspan="1">0.72 (0.64-0.90)</td><td align="left" rowspan="1" colspan="1">0.74 (0.57-0.82)</td><td align="left" rowspan="1" colspan="1">0.85 (0.80-0.88)</td><td align="left" rowspan="1" colspan="1">0.57 (0.52-0.75)</td></tr><tr><td align="left" rowspan="1" colspan="1">rf</td><td align="left" rowspan="1" colspan="1">0.73 (0.70-0.77)</td><td align="left" rowspan="1" colspan="1">0.65 (0.54-0.78)</td><td align="left" rowspan="1" colspan="1">0.63 (0.56-0.77)</td><td align="left" rowspan="1" colspan="1">0.64 (0.60-0.69)</td><td align="left" rowspan="1" colspan="1">0.83 (0.70-0.92)</td><td align="left" rowspan="1" colspan="1">0.63 (0.56-0.77)</td><td align="left" rowspan="1" colspan="1">0.82 (0.79-0.87)</td><td align="left" rowspan="1" colspan="1">0.65 (0.54-0.78)</td></tr><tr><td align="left" rowspan="1" colspan="1">cforest</td><td align="left" rowspan="1" colspan="1">0.72 (0.69-0.76)</td><td align="left" rowspan="1" colspan="1">0.66 (0.49-0.77)</td><td align="left" rowspan="1" colspan="1">0.60 (0.50-0.85)</td><td align="left" rowspan="1" colspan="1">0.63 (0.57-0.68)</td><td align="left" rowspan="1" colspan="1">0.85 (0.62-0.92)</td><td align="left" rowspan="1" colspan="1">0.60 (0.50-0.85)</td><td align="left" rowspan="1" colspan="1">0.81 (0.77-0.89)</td><td align="left" rowspan="1" colspan="1">0.66 (0.49-0.77)</td></tr><tr><td align="left" rowspan="1" colspan="1">RRF</td><td align="left" rowspan="1" colspan="1">0.71 (0.68-0.74)</td><td align="left" rowspan="1" colspan="1">0.60 (0.52-0.69)</td><td align="left" rowspan="1" colspan="1">0.63 (0.54-0.73)</td><td align="left" rowspan="1" colspan="1">0.62 (0.57-0.66)</td><td align="left" rowspan="1" colspan="1">0.79 (0.67-0.86)</td><td align="left" rowspan="1" colspan="1">0.63 (0.54-0.73)</td><td align="left" rowspan="1" colspan="1">0.81 (0.77-0.85)</td><td align="left" rowspan="1" colspan="1">0.60 (0.52-0.69)</td></tr><tr><td align="left" rowspan="1" colspan="1">fda</td><td align="left" rowspan="1" colspan="1">0.71 (0.68-0.74)</td><td align="left" rowspan="1" colspan="1">0.64 (0.50-0.71)</td><td align="left" rowspan="1" colspan="1">0.58 (0.51-0.77)</td><td align="left" rowspan="1" colspan="1">0.61 (0.55-0.66)</td><td align="left" rowspan="1" colspan="1">0.84 (0.64-0.88)</td><td align="left" rowspan="1" colspan="1">0.58 (0.51-0.77)</td><td align="left" rowspan="1" colspan="1">0.80 (0.77-0.85)</td><td align="left" rowspan="1" colspan="1">0.64 (0.50-0.71)</td></tr><tr><td align="left" rowspan="1" colspan="1">xgbLinear</td><td align="left" rowspan="1" colspan="1">0.71 (0.67-0.75)</td><td align="left" rowspan="1" colspan="1">0.64 (0.48-0.71)</td><td align="left" rowspan="1" colspan="1">0.57 (0.53-0.82)</td><td align="left" rowspan="1" colspan="1">0.60 (0.56-0.67)</td><td align="left" rowspan="1" colspan="1">0.84 (0.58-0.88)</td><td align="left" rowspan="1" colspan="1">0.57 (0.53-0.82)</td><td align="left" rowspan="1" colspan="1">0.80 (0.77-0.88)</td><td align="left" rowspan="1" colspan="1">0.64 (0.48-0.71)</td></tr><tr><td align="left" rowspan="1" colspan="1">C5.0</td><td align="left" rowspan="1" colspan="1">0.70 (0.67-0.74)</td><td align="left" rowspan="1" colspan="1">0.55 (0.49-0.75)</td><td align="left" rowspan="1" colspan="1">0.68 (0.47-0.81)</td><td align="left" rowspan="1" colspan="1">0.61 (0.55-0.66)</td><td align="left" rowspan="1" colspan="1">0.72 (0.60-0.92)</td><td align="left" rowspan="1" colspan="1">0.68 (0.47-0.81)</td><td align="left" rowspan="1" colspan="1">0.82 (0.76-0.87)</td><td align="left" rowspan="1" colspan="1">0.55 (0.49-0.75)</td></tr><tr><td align="left" rowspan="1" colspan="1">earth</td><td align="left" rowspan="1" colspan="1">0.70 (0.67-0.74)</td><td align="left" rowspan="1" colspan="1">0.56 (0.48-0.70)</td><td align="left" rowspan="1" colspan="1">0.65 (0.53-0.78)</td><td align="left" rowspan="1" colspan="1">0.60 (0.56-0.66)</td><td align="left" rowspan="1" colspan="1">0.75 (0.61-0.87)</td><td align="left" rowspan="1" colspan="1">0.65 (0.53-0.78)</td><td align="left" rowspan="1" colspan="1">0.81 (0.77-0.86)</td><td align="left" rowspan="1" colspan="1">0.56 (0.48-0.70)</td></tr><tr><td align="left" rowspan="1" colspan="1">gcvEarth</td><td align="left" rowspan="1" colspan="1">0.70 (0.68-0.74)</td><td align="left" rowspan="1" colspan="1">0.57 (0.46-0.66)</td><td align="left" rowspan="1" colspan="1">0.65 (0.58-0.82)</td><td align="left" rowspan="1" colspan="1">0.61 (0.58-0.67)</td><td align="left" rowspan="1" colspan="1">0.76 (0.59-0.84)</td><td align="left" rowspan="1" colspan="1">0.65 (0.58-0.82)</td><td align="left" rowspan="1" colspan="1">0.81 (0.78-0.88)</td><td align="left" rowspan="1" colspan="1">0.57 (0.46-0.66)</td></tr><tr><td align="left" rowspan="1" colspan="1">pda2</td><td align="left" rowspan="1" colspan="1">0.68 (0.65-0.73)</td><td align="left" rowspan="1" colspan="1">0.59 (0.51-0.70)</td><td align="left" rowspan="1" colspan="1">0.56 (0.45-0.63)</td><td align="left" rowspan="1" colspan="1">0.58 (0.51-0.63)</td><td align="left" rowspan="1" colspan="1">0.80 (0.73-0.88)</td><td align="left" rowspan="1" colspan="1">0.56 (0.45-0.63)</td><td align="left" rowspan="1" colspan="1">0.79 (0.75-0.83)</td><td align="left" rowspan="1" colspan="1">0.59 (0.51-0.70)</td></tr><tr><td align="left" rowspan="1" colspan="1">kernelpls</td><td align="left" rowspan="1" colspan="1">0.67 (0.64-0.72)</td><td align="left" rowspan="1" colspan="1">0.55 (0.47-0.63)</td><td align="left" rowspan="1" colspan="1">0.57 (0.48-0.73)</td><td align="left" rowspan="1" colspan="1">0.56 (0.51-0.63)</td><td align="left" rowspan="1" colspan="1">0.77 (0.61-0.83)</td><td align="left" rowspan="1" colspan="1">0.57 (0.48-0.73)</td><td align="left" rowspan="1" colspan="1">0.78 (0.75-0.83)</td><td align="left" rowspan="1" colspan="1">0.55 (0.47-0.63)</td></tr><tr><td align="left" rowspan="1" colspan="1">pls</td><td align="left" rowspan="1" colspan="1">0.67 (0.64-0.72)</td><td align="left" rowspan="1" colspan="1">0.55 (0.47-0.65)</td><td align="left" rowspan="1" colspan="1">0.58 (0.47-0.73)</td><td align="left" rowspan="1" colspan="1">0.56 (0.51-0.63)</td><td align="left" rowspan="1" colspan="1">0.76 (0.60-0.85)</td><td align="left" rowspan="1" colspan="1">0.58 (0.47-0.73)</td><td align="left" rowspan="1" colspan="1">0.78 (0.75-0.83)</td><td align="left" rowspan="1" colspan="1">0.55 (0.47-0.65)</td></tr><tr><td align="left" rowspan="1" colspan="1">simpls</td><td align="left" rowspan="1" colspan="1">0.67 (0.64-0.71)</td><td align="left" rowspan="1" colspan="1">0.54 (0.46-0.64)</td><td align="left" rowspan="1" colspan="1">0.58 (0.44-0.75)</td><td align="left" rowspan="1" colspan="1">0.56 (0.50-0.63)</td><td align="left" rowspan="1" colspan="1">0.75 (0.58-0.87)</td><td align="left" rowspan="1" colspan="1">0.58 (0.44-0.75)</td><td align="left" rowspan="1" colspan="1">0.78 (0.75-0.83)</td><td align="left" rowspan="1" colspan="1">0.54 (0.46-0.64)</td></tr><tr><td align="left" rowspan="1" colspan="1">widekernelpls</td><td align="left" rowspan="1" colspan="1">0.67 (0.64-0.72)</td><td align="left" rowspan="1" colspan="1">0.54 (0.47-0.63)</td><td align="left" rowspan="1" colspan="1">0.58 (0.48-0.73)</td><td align="left" rowspan="1" colspan="1">0.56 (0.50-0.63)</td><td align="left" rowspan="1" colspan="1">0.75 (0.59-0.83)</td><td align="left" rowspan="1" colspan="1">0.58 (0.48-0.73)</td><td align="left" rowspan="1" colspan="1">0.78 (0.75-0.83)</td><td align="left" rowspan="1" colspan="1">0.54 (0.47-0.63)</td></tr><tr><td align="left" rowspan="1" colspan="1">C5.0Tree</td><td align="left" rowspan="1" colspan="1">0.65 (0.61-0.70)</td><td align="left" rowspan="1" colspan="1">0.56 (0.40-0.61)</td><td align="left" rowspan="1" colspan="1">0.49 (0.41-0.88)</td><td align="left" rowspan="1" colspan="1">0.52 (0.46-0.60)</td><td align="left" rowspan="1" colspan="1">0.80 (0.40-0.85)</td><td align="left" rowspan="1" colspan="1">0.49 (0.41-0.88)</td><td align="left" rowspan="1" colspan="1">0.76 (0.72-0.88)</td><td align="left" rowspan="1" colspan="1">0.56 (0.40-0.61)</td></tr><tr><td align="left" rowspan="1" colspan="1">rpart</td><td align="left" rowspan="1" colspan="1">0.64 (0.60-0.67)</td><td align="left" rowspan="1" colspan="1">0.60 (0.54-0.74)</td><td align="left" rowspan="1" colspan="1">0.43 (0.30-0.46)</td><td align="left" rowspan="1" colspan="1">0.50 (0.41-0.54)</td><td align="left" rowspan="1" colspan="1">0.86 (0.83-0.93)</td><td align="left" rowspan="1" colspan="1">0.43 (0.30-0.46)</td><td align="left" rowspan="1" colspan="1">0.75 (0.71-0.78)</td><td align="left" rowspan="1" colspan="1">0.60 (0.54-0.74)</td></tr><tr><td align="left" rowspan="1" colspan="1">ctree</td><td align="left" rowspan="1" colspan="1">0.63 (0.60-0.69)</td><td align="left" rowspan="1" colspan="1">0.48 (0.43-0.55)</td><td align="left" rowspan="1" colspan="1">0.58 (0.52-0.75)</td><td align="left" rowspan="1" colspan="1">0.53 (0.49-0.60)</td><td align="left" rowspan="1" colspan="1">0.69 (0.56-0.76)</td><td align="left" rowspan="1" colspan="1">0.58 (0.52-0.75)</td><td align="left" rowspan="1" colspan="1">0.77 (0.74-0.83)</td><td align="left" rowspan="1" colspan="1">0.48 (0.43-0.55)</td></tr><tr><td align="left" rowspan="1" colspan="1">nnet</td><td align="left" rowspan="1" colspan="1">0.63 (0.59-0.66)</td><td align="left" rowspan="1" colspan="1">0.56 (0.49-0.72)</td><td align="left" rowspan="1" colspan="1">0.42 (0.28-0.52)</td><td align="left" rowspan="1" colspan="1">0.48 (0.37-0.55)</td><td align="left" rowspan="1" colspan="1">0.83 (0.77-0.93)</td><td align="left" rowspan="1" colspan="1">0.42 (0.28-0.52)</td><td align="left" rowspan="1" colspan="1">0.74 (0.70-0.78)</td><td align="left" rowspan="1" colspan="1">0.56 (0.49-0.72)</td></tr><tr><td align="left" rowspan="1" colspan="1">knn</td><td align="left" rowspan="1" colspan="1">0.59 (0.56-0.63)</td><td align="left" rowspan="1" colspan="1">0.52 (0.38-0.65)</td><td align="left" rowspan="1" colspan="1">0.33 (0.18-0.69)</td><td align="left" rowspan="1" colspan="1">0.41 (0.28-0.54)</td><td align="left" rowspan="1" colspan="1">0.84 (0.48-0.94)</td><td align="left" rowspan="1" colspan="1">0.33 (0.18-0.69)</td><td align="left" rowspan="1" colspan="1">0.72 (0.68-0.77)</td><td align="left" rowspan="1" colspan="1">0.52 (0.38-0.65)</td></tr><tr><td align="left" rowspan="1" colspan="1">LogitBoost</td><td align="left" rowspan="1" colspan="1">0.58 (0.55-0.60)</td><td align="left" rowspan="1" colspan="1">0.75 (0.61-0.86)</td><td align="left" rowspan="1" colspan="1">0.18 (0.13-0.24)</td><td align="left" rowspan="1" colspan="1">0.29 (0.22-0.37)</td><td align="left" rowspan="1" colspan="1">0.97 (0.95-0.98)</td><td align="left" rowspan="1" colspan="1">0.18 (0.13-0.24)</td><td align="left" rowspan="1" colspan="1">0.70 (0.67-0.75)</td><td align="left" rowspan="1" colspan="1">0.75 (0.61-0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">kknn</td><td align="left" rowspan="1" colspan="1">0.50 (0.50-0.50)</td><td align="center" rowspan="1" colspan="1">Na</td><td align="left" rowspan="1" colspan="1">0.00 (0.00-0.00)</td><td align="center" rowspan="1" colspan="1">Na</td><td align="left" rowspan="1" colspan="1">1.00 (1.00-1.00)</td><td align="left" rowspan="1" colspan="1">0.00 (0.00-0.00)</td><td align="left" rowspan="1" colspan="1">0.67 (0.67-0.67)</td><td align="center" rowspan="1" colspan="1">Na</td></tr></tbody></table><table-wrap-foot><fn id="tbl2-fn1"><p>Accuracy: (TP&#160;+&#160;TN)/(P&#160;+&#160;N)&#8212;Overall classification correctness</p></fn><fn id="tbl2-fn2"><p>Precision (PPV): TP/(TP&#160;+&#160;FP)&#8212;Positive predictive value</p></fn><fn id="tbl2-fn3"><p>Recall (Sensitivity): TP/(TP&#160;+&#160;FN)&#8212;True positive rate</p></fn><fn id="tbl2-fn4"><p>Specificity: TN/(TN&#160;+&#160;FP)&#8212;True negative rate</p></fn><fn id="tbl2-fn5"><p>F1-score: 2*(Precision*Recall)/(Precision&#160;+&#160;Recall)&#8212;Harmonic mean</p></fn><fn id="tbl2-fn6"><p>NPV: TN/(TN&#160;+&#160;FN)&#8212;Negative predictive value</p></fn><fn id="tbl2-fn7"><p>All performance metrics were computed with 95% confidence intervals derived through non-parametric bootstrap resampling.</p></fn><fn id="tbl2-fn8"><p>N, negative; NPV, negative predictive value; P, positive; PPV, positive predictive value; TN, true negative; TP, true positive.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec><title>Model validation</title><p>The performance of SAFE-Mo was validated using an internal validation set. In the confusion matrix, the number of 26-day mortality true negative results was 367, true positive results were 157, false negatives numbered 74, and false positives were 93. SAFE-Mo achieved a specificity/sensitivity/accuracy of 0.7978, 0.6797, and 0.7387, respectively (Fig. <xref rid="F4" ref-type="fig">4</xref>B). Further validation of SAFE-Mo&#8217;s performance was conducted using external validation sets one and two. In the set one, the confusion matrix showed 927 true negative results, 413 true positive results, 207 false negatives, and 255 false positives based on 26-day mortality. The specificity, sensitivity, and accuracy for SAFE-Mo were 0.8175, 0.6183, and 0.7179, respectively (Fig. <xref rid="F4" ref-type="fig">4</xref>C). In external validation set two, the confusion matrix demonstrated 178 true negative results, 90 true positive results, 153 false negatives, and 17 false positives based on 26-day mortality. The specificity, sensitivity, and accuracy for SAFE-Mo were 0.5378, 0.8411, and 0.6894, respectively (Fig. <xref rid="F4" ref-type="fig">4</xref>D)</p></sec><sec><title>Model comparison</title><p>Comparative performance evaluation of SAFE-Mo against four clinical risk assessment models was conducted using the internal validation set. Figure <xref rid="F5" ref-type="fig">5</xref>A demonstrates superior discriminative capacity of SAFE-Mo in 26-day mortality prediction (AUC&#160;=&#160;0.814). Univariate logistic regression analyses revealed statistically significant odds ratio (OR) variations across all models, with SAFE-Mo exhibiting the maximal effect size (OR&#160;=&#160;168.94, 95% CI 74.91&#8211;381.01; <italic toggle="yes">P</italic>&lt;0.001). Multivariate regression models confirmed significant predictive associations for SAFE-Mo (adjusted OR&#160;=&#160;55.17, 95% CI 20.20&#8211;150.71), CCI, and SOFA scores, where SAFE-Mo maintained the strongest prognostic relationship (Supplemental Digital Content, Table S4 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E465" ext-link-type="uri">http://links.lww.com/JS9/E465</ext-link>; Fig. S4A <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E461" ext-link-type="uri">http://links.lww.com/JS9/E461</ext-link>). Correlation analyses identified the highest association between SAFE-Mo and SAPSII (Pearson&#8217;s <italic toggle="yes">r</italic> =&#160;0.63, <italic toggle="yes">P</italic>&lt;0.001) (Supplemental Digital Content, Fig. S4B <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E461" ext-link-type="uri">http://links.lww.com/JS9/E461</ext-link>).
<fig position="float" id="F5" orientation="portrait"><label>Figure 5.</label><caption><p>ROC curves and the clinical utility assessment of SAFE-Mo, APSIII, SAPS II, SOFA, and CCI for predicting 26-day mortality using validation set. (A) ROC curves in internal validation. (B) ROC curves in external validation set one. (C) SAFE-Mo&#8217; ROC curve in external validation set two. (D) DCA of each model using the internal validation set. (E) Calibration curves of each model in internal validation (F) DCA of each model using external validation set one (G) Calibration curves of each model in external validation set one. <italic toggle="yes">DCA</italic> decision curve analysis; <italic toggle="yes">SAFE-Mo</italic> Sepsis-associated ARDS fatality evaluation model.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6008-g005.jpg"/></fig>
</p><p>The analysis of external validation set one replicated these findings, with SAFE-Mo achieving the predictive accuracy (AUC&#160;=&#160;0.782) for 26-day mortality (Fig. <xref rid="F5" ref-type="fig">5</xref>B). Univariate comparisons demonstrated significant OR heterogeneity among models, where SAFE-Mo retained the most substantial risk association (OR&#160;=&#160;80.59, 95% CI 50.03&#8211;129.82). Multivariate adjustments preserved significant predictive values for SAFE-Mo (OR&#160;=&#160;38.86, 95% CI 23.07&#8211;65.47), SAPSII, and SOFA scores, confirming SAFE-Mo&#8217;s persistent dominance (Supplemental Digital Content, Table S5, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E466" ext-link-type="uri">http://links.lww.com/JS9/E466</ext-link>; Fig. S4C, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E461" ext-link-type="uri">http://links.lww.com/JS9/E461</ext-link>). Notably, correlation patterns shifted in this cohort, showing maximal association between SAFE-Mo and SOFA score (<italic toggle="yes">r</italic> =&#160;0.42, <italic toggle="yes">P</italic>&lt;0.001) (Supplemental Digital Content, Fig. S4D, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E461" ext-link-type="uri">http://links.lww.com/JS9/E461</ext-link>). Analyses utilizing external validation set two evaluated the model&#8217;s clinical adaptability, demonstrating preserved 26-day mortality prediction accuracy (AUC&#160;=&#160;0.747) under four-variable missing conditions (Fig. <xref rid="F5" ref-type="fig">5</xref>C).</p></sec><sec><title>Clinical utility</title><p>To objectively assess the clinical utility of SAFE-Mo in predicting 26-day mortality, DCA and calibration analysis were conducted. In the internal validation set, DCA results indicated that SAFE-Mo had an appropriate risk threshold range of 0.2 to 0.8. Within this range, net clinical benefit was higher (Fig. <xref rid="F5" ref-type="fig">5</xref>D). Calibration curve analysis demonstrated consistency between predicted probabilities and actual outcomes for APS III, SOFA, and SAFE-Mo; the predicted probabilities from SAFE-Mo were slightly overestimated compared to the actual outcomes (Fig. <xref rid="F5" ref-type="fig">5</xref>E).</p><p>In the external validation set, overall, SAFE-Mo had an appropriate risk threshold range of 0.2 to 0.7, indicating higher net clinical benefit within this range (Fig. <xref rid="F5" ref-type="fig">5</xref>F). Calibration curve analysis showed that APS III, SAPS II, and SOFA maintained a high level of consistency between predicted and actual outcomes. Notably, when actual probabilities were between 0.2 and 0.58, the predicted probabilities from SAFE-Mo were overestimated compared to the actual outcomes (Fig. <xref rid="F5" ref-type="fig">5</xref>G). Considering the potential possibility of our model being used in clinical practice in the future, a simple front-end web page was made (Supplemental Digital Content, Table S6, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E467" ext-link-type="uri">http://links.lww.com/JS9/E467</ext-link>) to facilitate clinicians to quickly view the patients&#8217; SAFE-Mo index and preliminarily determine their mortality risk and provide better clinical resource utilization.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Mortality rates in patients with sepsis-associated ARDS remain high, with only minimal improvements observed in recent years, now stabilizing at approximately 40%<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R26" ref-type="bibr">26</xref>]</sup>. Therefore, constructing a predictive model capable of early identification of patients likely to experience mortality is essential for guiding appropriate interventions and optimizing resource allocation. This study developed and validated a clinical prediction model, SAFE-Mo, using three independent databases: the MIMIC-IV, eICU CRD, and NWICU. SAFE-Mo demonstrated good calibration and discrimination in internal validation and external validation set one. In clinical practice, the lack of partial information about patients is a common situation. In the external validation set two where four pieces of information were missing, the AUC of SAFE-Mo was still 0.747, which indicated that SAFE-Mo had sufficiently stable predictive power. Predictors included in SAFE-Mo are biologically plausible, encompassing demographic data, vital signs, serological markers, and comorbidity indicators, all readily extractable from medical records. SAFE-Mo performed excellently in predicting early mortality risk in patients with sepsis-associated ARDS, providing strong support for clinical decision-making.</p><p>Parameters within the model exhibit multicollinearity, which can exacerbate the tension between optimization and generalization, ultimately leading to model overfitting and hindering the generalizability of discriminant functions<sup>[<xref rid="R27" ref-type="bibr">27</xref>]</sup>. To enhance the reliability of selected variables, Lasso regression analysis was used to address collinearity issues. After processing, kappa values indicated a significant reduction in collinearity. A total of 32 variables were included in SAFE-Mo. Post-modeling variable importance analysis revealed that lactate min, lactate max, urine output, and anion gap min had high explanatory power.</p><p>Lactate emerged as the most critical variable in SAFE-Mo, with significant predictive and prognostic value. In critically ill patients with sepsis, lactate levels frequently increase, reflecting a mismatch between production and clearance rates. Patients with lung injury produce lactate more rapidly<sup>[<xref rid="R28" ref-type="bibr">28</xref>]</sup>, possibly due to inflammatory cytokines released by immune cells and elevated catecholamine levels post-stress, promoting glycolysis. Additionally, lactate clearance significantly decreases in sepsis patients<sup>[<xref rid="R29" ref-type="bibr">29</xref>&#8211;<xref rid="R32" ref-type="bibr">32</xref>]</sup>. Given that lactate is influenced by multiple factors, relying solely on lactate levels to determine tissue hypoxia is not advisable<sup>[<xref rid="R33" ref-type="bibr">33</xref>]</sup>. The anion gap serves as an important indicator of acid-base balance<sup>[<xref rid="R34" ref-type="bibr">34</xref>]</sup>. Rapid increases in lactate levels in sepsis-related ARDS patients can easily lead to acid-base disturbances, elevating the anion gap. The lungs, as one of the target organs for sepsis and an acid-base regulatory organ, can cause rapid systemic acid-base imbalances when dysfunctional. Key variables in SAFE-Mo include lactate, anion gap, sodium, potassium, and pH, all reflecting the body&#8217;s acid-base status. This suggests that acid-base balance may be a critical factor influencing early mortality risk in sepsis-related ARDS patients.</p><p>Urine output, another key variable, reflects circulatory volume and fluid management. Many studies indicate that low urine output correlates with higher mortality in sepsis patients<sup>[<xref rid="R35" ref-type="bibr">35</xref>,<xref rid="R36" ref-type="bibr">36</xref>]</sup>. However, further research is needed when the urine output/fluid intake ratio is &#8805;0.5<sup>[<xref rid="R37" ref-type="bibr">37</xref>]</sup>. Therefore, dynamic fluid management is necessary for sepsis-related ARDS patients rather than absolute urine output values.</p><p>Combining baseline data with variable importance analysis revealed that comorbidities involving organs, particularly the heart, liver, and kidneys, substantially influenced early mortality risk in patients. The crosstalk between these organs constitutes one of the main mechanisms by which the body performs normal physiological functions and sustains life<sup>[<xref rid="R38" ref-type="bibr">38</xref>]</sup>. Patients with sepsis are more susceptible to organ dysfunction, and the presence of comorbidities affecting multiple organs further disrupts inter-organ communication. Consequently, imbalances in respiration, blood pressure, organ perfusion, and coagulation contribute to high mortality risks. Malignant cancers and metastatic tumors also emerged as critical factors, as they or the immunotherapy received by patients can impact both innate and adaptive immunity; they may exacerbate the severity of sepsis and complicate clinicians&#8217; assessments of patient immune status<sup>[<xref rid="R39" ref-type="bibr">39</xref>]</sup>. Therefore, focusing on the management of comorbidities and implementing personalized precision therapies can help mitigate the early mortality risk in patients with sepsis-associated ARDS.</p><p>Given the time of deaths in the training set is skewed, the median is statistically a better way to describe the overall average. Median survival time is used to differentiate early from late mortality. In this study, early mortality was defined as occurring within 26&#160;days, aiding in identifying patients who may respond poorly to treatment or have more severe conditions<sup>[<xref rid="R40" ref-type="bibr">40</xref>]</sup>. SAFE-Mo was compared against various ML algorithms and traditional clinical risk prediction models (including SOFA, APS III, SAPSII, and CCI). Both internal and external validations confirmed SAFE-Mo&#8217;s superior AUC. Further DCA curve analyses validated SAFE-Mo&#8217;s clinical utility, demonstrating the largest reasonable risk threshold probability range and highest net benefit compared to other models. We also compared SAFE-Mo with a recently published Clinical Prediction Model (CPM) (Supplemental Digital Content, Table S7 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E763" ext-link-type="uri">http://links.lww.com/JS9/E763</ext-link>). In predicting early mortality risk, SAFE-Mo demonstrated superior performance relative to the CPM. Calibration curves indicated that SAFE-Mo slightly overestimated mortality risk overall. Several factors may underlie this result, the most plausible being a mismatch in baseline risk between the training and validation datasets. In the development cohort, the event rate may have been higher than in our validation cohort, causing the model to overestimate risk among individuals who are in fact at low risk. Alternatively, a limited sample size and a small number of events can make the model prone to overfitting the high-risk cases in the training data when positive outcomes are scarce. Clinically, this tendency of SAFE-Mo may be advantageous: by amplifying early risk signals, it can increase the sensitivity of warnings, reduce missed detections of rare but critical events, and thereby maximize the benefits of prompt intervention. Although SAFE-Mo exhibits a slight overall overestimation of risk at the calibration level, decision-analytic and cost-effectiveness considerations suggest that this bias may improve early warning performance, enhance patient safety, and provide strong impetus for subsequent model recalibration and ongoing learning.</p><p>Overall, compared to traditional models, SAFE-Mo exhibited superior predictive capability of early mortality. SAFE-Mo has the potential to assist clinicians in identifying high-risk patients early, like patients with unusually high levels of lactate in sepsis-associated ARDS, assessing prognosis, and facilitating risk-adjusted comparisons of center-specific outcomes. Practical advantages in clinical settings include guiding personalized treatment strategies, determining the need for aggressive interventions, and optimizing resource utilization. SAFE-Mo also aids in deciding the most appropriate care environment, such as distinguishing patients requiring transfer to the ICU for close monitoring and intensive therapy from those who can receive routine care in non-ICU settings.</p><p>In our study, several limitations should be acknowledged. First, the retrospective and observational nature of the study may introduce selection bias. Treatment and medication protocols evolved over time during the data collection phase, potentially affecting patient outcomes and mortality risks. Second, while the MIMIC-IV database originates from a single United States center, the use of the multi-center eICU CRD database for validation might limit SAFE-Mo&#8217;s applicability to sepsis-associated ARDS patients in other countries/regions. In the NWICU dataset, the median from MIMIC-IV is used to replace the very few 100% missing variables, which is a necessary trade-off in the real world, but it may affect the independence of external validation to a certain extent, and a more complete validation set data should be obtained to supplement it in the future ideal scenario. Absence of multicenter prospective cohort studies hinders broader generalization. Lastly, despite imputed data being similar to true results, some selection bias remains possible. Moreover, imaging data and other outcome-influencing factors such as treatment strategies and nursing levels were not considered. Thereby, further validation in prospective, multicenter, large-scale patient datasets will provide stronger evidence for the efficacy and generalizability of SAFE-Mo.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>This study utilized the MIMIC-IV, eICU CRD, and NWICU databases to construct and validate a ML model, SAFE-Mo, which predicts early mortality in patients with sepsis-associated ARDS and outperforms traditional prediction models across all metrics. SAFE-Mo can guide clinicians to focus on critical indicators such as lactate, urine output, anion gap, and others, enabling appropriate measures to improve clinical outcomes for high-risk patients.</p></sec></body><back><ack><title>Acknowledgements</title><p>We acknowledge all participants in the eICU, MIMIC-IV, and NWICU studies, the Laboratory for Computational Physiology team from the Massachusetts Institute of Technology who maintain the eICU CRD, MIMIC-IV, and NWICU databases, and the help of BioRender (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.biorender.com" ext-link-type="uri">https://www.biorender.com</ext-link>) with our graphics.</p></ack><fn-group><fn fn-type="other"><p>Luofeng Jiang, Chuting Yu, and Chaoran Xie contributed equally to this work</p></fn><fn fn-type="other"><p>Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal&#8217;s website, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.lww.com/international-journal-of-surgery" ext-link-type="uri">www.lww.com/international-journal-of-surgery</ext-link>.</p></fn><fn fn-type="equal"><p>Published online 25 June 2025</p></fn></fn-group><sec><title>Ethical approval</title><p>The study analyzed only de-identified, publicly available intensive-care databases that are distributed through the PhysioNet platform. Each database has passed ethics review.</p><p><italic toggle="yes">MIMIC-IV, v 3.0.</italic> The collection of patient information and creation of the research resource was reviewed by the Institutional Review Board at the Beth Israel Deaconess Medical Center, who granted a waiver of informed consent and approved the data sharing initiative.</p><p><italic toggle="yes">eICU-CRD, v 2.0.</italic> The database was established with approval from the Philips Healthcare IRB and the MIT IRB. The study is exempt from institutional review board approval due to the retrospective design, lack of direct patient intervention, and the security schema, for which the re-identification risk was certified as meeting safe harbor standards by an independent privacy expert (Privacert, Cambridge, MA) (Health Insurance Portability and Accountability Act Certification no. 1031219-2).</p><p><italic toggle="yes">NWICU, v 0.1</italic>. The project was approved by the Institutional Review Boards of Beth Israel Deaconess Medical Center (Boston, MA) and the Massachusetts Institute of Technology (Cambridge, MA). Requirement for individual patient consent was waived because the project did not impact clinical care and all protected health information was de-identified. The NU IRB approved participation in the project and granted a waiver of informed consent based on the minimal risk and impracticality of obtaining specific consent from the large number of patients. Release of data from the NM EDW was additionally approved by the NM Data Steward.</p><p>All three datasets have undergone irreversible de-identification that meets the HIPAA Safe-Harbor standard. Before downloading any data, the author LF J has completed the CITI Program course &#8220;Data or Specimens Only Research&#8221; (No. 50&#160;140&#160;789) and signed the corresponding PhysioNet Data Use Agreements (Supplemental Digital Content, Table S1 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/JS9/E462" ext-link-type="uri">http://links.lww.com/JS9/E462</ext-link>).</p></sec><sec><title>Consent</title><p>Not applicable.</p></sec><sec><title>Sources of funding</title><p>This work was funded by National Natural Science Foundation of China (81930057), CAMS Innovation Fund for Medical Sciences (2019-I2M-5-076), Lab of Treatment of War Wounds During Amphibious Operations, and Clinical Key Discipline Project of Shanghai, PLA and PRC, Key Research Center Construction Project of Shanghai (2023ZZ2013), and Major/Key Logistics Research Projects (AHJ24J005, JKBWS23C1018). The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report.</p></sec><sec><title>Author contributions</title><p>L.F.J., C.T.Y., C.R.X., Y.J.Z., and Z.F.X. conceived the idea. L.F.J. and C.T.Y. did most of the data analysis, model construction, model validation, and made the visualization of data. C.R.X. helped in the visualization of data. Y.J.Z. and Z.F.X. read the manuscript carefully. L.F.J., C.T.Y., and C.X. prepared the final manuscript.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest disclosure</title><p>The authors declare that they have no competing interests or personal relationships that could have appeared to influence the work reported in this paper.</p></sec><sec><title>Guarantor</title><p>Luofeng Jiang, YongJun Zheng, and Zhaofan Xia.</p></sec><sec><title>Research registration unique identifying number (UIN)</title><p>Not applicable.</p></sec><sec><title>Provenance and peer review</title><p>Our paper was not invited.</p></sec><sec sec-type="data-availability"><title>Data availability statement</title><p>The data that support the findings of this study are available from PhysioNet (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://physionet.org/" ext-link-type="uri">https://physionet.org/</ext-link>) but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are, however, available from the authors upon reasonable request and with permission of PhysioNet (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://physionet.org/" ext-link-type="uri">https://physionet.org/</ext-link>). The complete analysis code, including data preprocessing, model development, and validation pipelines, has been deposited in our GitHub repository: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/ChutingY/SAFE-Mo" ext-link-type="uri">https://github.com/ChutingY/SAFE-Mo</ext-link>.</p></sec><sec><title>Declaration of Generative AI and AI-assisted technologies in the language drafting</title><p>During the preparation of this work the authors used Tongyiqianwen (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://tongyi.aliyun.com" ext-link-type="uri">https://tongyi.aliyun.com</ext-link>) in language drafting. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication. No conflicts of interest or financial ties with AI vendors are present.</p></sec><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bellani</surname><given-names>G</given-names></name><name name-style="western"><surname>Laffey</surname><given-names>JG</given-names></name><name name-style="western"><surname>Pham</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 Countries</article-title>. <source>JAMA</source><year>2016</year>;<volume>315</volume>:<fpage>788&#8211;800</fpage>.<pub-id pub-id-type="pmid">26903337</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2016.0291</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wheeler</surname><given-names>AP</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>GR</given-names></name></person-group>. <article-title>Acute lung injury and the acute respiratory distress syndrome: a clinical review</article-title>. <source>Lancet</source><year>2007</year>;<volume>369</volume>:<fpage>1553&#8211;64</fpage>.<pub-id pub-id-type="pmid">17482987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(07)60604-7</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rudd</surname><given-names>KE</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>SC</given-names></name><name name-style="western"><surname>Agesa</surname><given-names>KM</given-names></name><etal/></person-group>. <article-title>Global, regional, and national sepsis incidence and mortality, 1990&#8211;2017: analysis for the Global Burden of Disease Study</article-title>. <source>Lancet</source><year>2020</year>;<volume>395</volume>:<fpage>200&#8211;11</fpage>.<pub-id pub-id-type="pmid">31954465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(19)32989-7</pub-id><pub-id pub-id-type="pmcid">PMC6970225</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Risk factors for acute respiratory distress syndrome in sepsis patients: a retrospective study from a tertiary hospital in China</article-title>. <source>BMC Pulm Med</source><year>2022</year>;<volume>22</volume>:<fpage>238</fpage>.<pub-id pub-id-type="pmid">35729588</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12890-022-02015-w</pub-id><pub-id pub-id-type="pmcid">PMC9210689</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villar</surname><given-names>J</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>J</given-names></name><name name-style="western"><surname>A&#241;&#243;n</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation</article-title>. <source>Intensive Care Med</source><year>2011</year>;<volume>37</volume>:<fpage>1932&#8211;41</fpage>.<pub-id pub-id-type="pmid">21997128</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00134-011-2380-4</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Auriemma</surname><given-names>CL</given-names></name><name name-style="western"><surname>Zhuo</surname><given-names>H</given-names></name><name name-style="western"><surname>Delucchi</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis</article-title>. <source>Intensive Care Med</source><year>2020</year>;<volume>46</volume>:<fpage>1222&#8211;31</fpage>.<pub-id pub-id-type="pmid">32206845</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00134-020-06010-9</pub-id><pub-id pub-id-type="pmcid">PMC7224051</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowell</surname><given-names>JC</given-names></name><name name-style="western"><surname>Parvathaneni</surname><given-names>K</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>NJ</given-names></name><etal/></person-group>. <article-title>Epidemiology of CAUSE OF DEATH IN PEDIATRIC ACUTE RESPIRATORY DISTRESS SYndrome</article-title>. <source>Crit Care Med</source><year>2018</year>;<volume>46</volume>:<fpage>1811&#8211;19</fpage>.<pub-id pub-id-type="pmid">30095498</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CCM.0000000000003371</pub-id><pub-id pub-id-type="pmcid">PMC6185780</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Theodosiou</surname><given-names>AA</given-names></name><name name-style="western"><surname>Read</surname><given-names>RC</given-names></name></person-group>. <article-title>Artificial intelligence, machine learning and deep learning: potential resources for the infection clinician</article-title>. <source>J Infect</source><year>2023</year>;<volume>87</volume>:<fpage>287&#8211;94</fpage>.<pub-id pub-id-type="pmid">37468046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jinf.2023.07.006</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bock</surname><given-names>C</given-names></name><name name-style="western"><surname>Walter</surname><given-names>JE</given-names></name><name name-style="western"><surname>Rieck</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Enhancing the diagnosis of functionally relevant coronary artery disease with machine learning</article-title>. <source>Nat Commun</source><year>2024</year>;<volume>15</volume>:<fpage>5034</fpage>.<pub-id pub-id-type="pmid">38866791</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-49390-y</pub-id><pub-id pub-id-type="pmcid">PMC11169272</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>C-T</given-names></name><name name-style="western"><surname>Tan</surname><given-names>EC-H</given-names></name><name name-style="western"><surname>Lee</surname><given-names>P-C</given-names></name><etal/></person-group>. <article-title>Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma</article-title>. <source>Clin Mol Hepatol</source><year>2024</year>;<volume>30</volume>:<fpage>406&#8211;20</fpage>.<pub-id pub-id-type="pmid">38600872</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3350/cmh.2024.0103</pub-id><pub-id pub-id-type="pmcid">PMC11261226</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zong</surname><given-names>C</given-names></name><name name-style="western"><surname>Zou</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>A novel clinical prediction model for in-hospital mortality in sepsis patients complicated by ARDS: a MIMIC IV database and external validation study</article-title>. <source>Heliyon</source><year>2024</year>;<volume>10</volume>:<fpage>e33337</fpage>.<pub-id pub-id-type="pmid">39027620</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.heliyon.2024.e33337</pub-id><pub-id pub-id-type="pmcid">PMC467048</pub-id></mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Du</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Machine learning for the early prediction of acute respiratory distress syndrome (ARDS) in patients with sepsis in the ICU based on clinical data</article-title>. <source>Heliyon</source><year>2024</year>;<volume>10</volume>:<fpage>e28143</fpage>.<pub-id pub-id-type="pmid">38533071</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.heliyon.2024.e28143</pub-id><pub-id pub-id-type="pmcid">PMC10963609</pub-id></mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu</surname><given-names>S</given-names></name><name name-style="western"><surname>Yan</surname><given-names>D</given-names></name><name name-style="western"><surname>Tang</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Predicting mortality in sepsis-associated acute respiratory distress syndrome: a machine learning approach using the MIMIC-III Database</article-title>. <source>J Intensive Care Med</source><year>2024</year>;<fpage>40:294&#8211;302</fpage>.<pub-id pub-id-type="pmid">39234770</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/08850666241281060</pub-id></mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agha</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mathew</surname><given-names>G</given-names></name><name name-style="western"><surname>Rashid</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Transparency In The reporting of Artificial INtelligence &#8211; the TITAN guideline</article-title>. <source>Prem J Sci</source><year>2025</year>;<volume>10</volume>:<fpage>100082</fpage>.</mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>AEW</given-names></name><name name-style="western"><surname>Pollard</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Shen</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>MIMIC-III, a freely accessible critical care database</article-title>. <source>Sci Data</source><year>2016</year>;<volume>3</volume>:<fpage>160035</fpage>.<pub-id pub-id-type="pmid">27219127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sdata.2016.35</pub-id><pub-id pub-id-type="pmcid">PMC4878278</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pollard</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>AEW</given-names></name><name name-style="western"><surname>Raffa</surname><given-names>JD</given-names></name><etal/></person-group>. <article-title>The eICU Collaborative Research Database, a freely available multi-center database for critical care research</article-title>. <source>Sci Data</source><year>2018</year>;<volume>5</volume>:<fpage>180178</fpage>.<pub-id pub-id-type="pmid">30204154</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sdata.2018.178</pub-id><pub-id pub-id-type="pmcid">PMC6132188</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldberger</surname><given-names>AL</given-names></name><name name-style="western"><surname>Amaral</surname><given-names>LA</given-names></name><name name-style="western"><surname>Glass</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals</article-title>. <source>Circulation</source><year>2000</year>;<volume>101</volume>:<fpage>E215</fpage>&#8211;<lpage>220</lpage>.<pub-id pub-id-type="pmid">10851218</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.cir.101.23.e215</pub-id></mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moukheiber</surname><given-names>D</given-names></name><name name-style="western"><surname>Temps</surname><given-names>W</given-names></name><name name-style="western"><surname>Molgi</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Northwestern ICU (NWICU) database (version 0.1.0)</article-title>. <source>PhysioNet</source> 2024. <fpage>RRID:SCR_007345</fpage>. doi:<pub-id pub-id-type="doi">10.13026/s84w-1829</pub-id>.</mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matthay</surname><given-names>MA</given-names></name><name name-style="western"><surname>Arabi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Arroliga</surname><given-names>AC</given-names></name><etal/></person-group>. <article-title>A new global definition of acute respiratory distress syndrome</article-title>. <source>Am J Respir Crit Care Med</source><year>2024</year>;<volume>209</volume>:<fpage>37&#8211;47</fpage>.<pub-id pub-id-type="pmid">37487152</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.202303-0558WS</pub-id><pub-id pub-id-type="pmcid">PMC10870872</pub-id></mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>FL</given-names></name><name name-style="western"><surname>Bota</surname><given-names>DP</given-names></name><name name-style="western"><surname>Bross</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Serial evaluation of the SOFA score to predict outcome in critically ill patients</article-title>. <source>JAMA</source><year>2001</year>;<volume>286</volume>:<fpage>1754&#8211;58</fpage>.<pub-id pub-id-type="pmid">11594901</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.286.14.1754</pub-id></mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knaus</surname><given-names>WA</given-names></name><name name-style="western"><surname>Zimmerman</surname><given-names>JE</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>DP</given-names></name><etal/></person-group>. <article-title>APACHE&#8212;acute physiology and chronic health evaluation: a physiologically based classification system</article-title>. <source>Crit Care Med</source><year>1981</year>;<volume>9</volume>:<fpage>591&#8211;97</fpage>.<pub-id pub-id-type="pmid">7261642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00003246-198108000-00008</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Gall</surname><given-names>JR</given-names></name><name name-style="western"><surname>Lemeshow</surname><given-names>S</given-names></name><name name-style="western"><surname>Saulnier</surname><given-names>F</given-names></name></person-group>. <article-title>A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study</article-title>. <source>JAMA</source><year>1993</year>;<volume>270</volume>:<fpage>2957&#8211;63</fpage>.<pub-id pub-id-type="pmid">8254858</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.270.24.2957</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charlson</surname><given-names>ME</given-names></name><name name-style="western"><surname>Carrozzino</surname><given-names>D</given-names></name><name name-style="western"><surname>Guidi</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Charlson comorbidity index: a critical review of clinimetric properties</article-title>. <source>Psychother Psychosom</source><year>2022</year>;<volume>91</volume>:<fpage>8&#8211;35</fpage>.<pub-id pub-id-type="pmid">34991091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000521288</pub-id></mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Buuren</surname><given-names>S</given-names></name></person-group>. <article-title>Groothuis-Oudshoorn K. mice: multivariate Imputation by Chained Equations in R</article-title>. <source>J Stat Softw</source><year>2011</year>;<volume>45</volume>:<fpage>1&#8211;67</fpage>.</mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>M</given-names></name></person-group>. <article-title>rmda: risk Model Decision Analysis 2018. R package version 1.6</article-title>. Accessed 24 May 2025. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://CRAN.R-project.org/package=rmda" ext-link-type="uri">https://CRAN.R-project.org/package=rmda</ext-link></mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phua</surname><given-names>J</given-names></name><name name-style="western"><surname>Badia</surname><given-names>JR</given-names></name><name name-style="western"><surname>Adhikari</surname><given-names>NKJ</given-names></name><etal/></person-group>. <article-title>Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review</article-title>. <source>Am J Respir Crit Care Med</source><year>2009</year>;<volume>179</volume>:<fpage>220&#8211;27</fpage>.<pub-id pub-id-type="pmid">19011152</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200805-722OC</pub-id></mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armitage</surname><given-names>DW</given-names></name><name name-style="western"><surname>Ober</surname><given-names>HK</given-names></name></person-group>. <article-title>A comparison of supervised learning techniques in the classification of bat echolocation calls</article-title>. <source>Ecol Inf</source><year>2010</year>;<volume>5</volume>:<fpage>465&#8211;73</fpage>.</mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gasparovic</surname><given-names>H</given-names></name><name name-style="western"><surname>Plestina</surname><given-names>S</given-names></name><name name-style="western"><surname>Sutlic</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Pulmonary lactate release following cardiopulmonary bypass</article-title>. <source>Eur J Cardiothorac Surg</source><year>2007</year>;<volume>32</volume>:<fpage>882&#8211;87</fpage>.<pub-id pub-id-type="pmid">17904857</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejcts.2007.09.001</pub-id></mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Developing a predictive nomogram for mortality in patients with extrapulmonary acute respiratory distress syndrome: the prognostic value of serum soluble thrombomodulin, lung ultrasound score, and lactate</article-title>. <source>Front Pharmacol</source><year>2024</year>;<volume>15</volume>:<fpage>1407825</fpage>.<pub-id pub-id-type="pmid">39257391</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2024.1407825</pub-id><pub-id pub-id-type="pmcid">PMC11385278</pub-id></mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wen</surname><given-names>J</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Lactate anions participate in T cell cytokine production and function</article-title>. <source>Sci China Life Sci</source><year>2021</year>;<volume>64</volume>:<fpage>1895&#8211;905</fpage>.<pub-id pub-id-type="pmid">33580429</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11427-020-1887-7</pub-id></mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Kueth</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Lactate&#8217;s impact on immune cells in sepsis: unraveling the complex interplay</article-title>. <source>Front Immunol</source><year>2024</year>;<volume>15</volume>:<fpage>1483400</fpage>.<pub-id pub-id-type="pmid">39372401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2024.1483400</pub-id><pub-id pub-id-type="pmcid">PMC11449721</pub-id></mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hernandez</surname><given-names>G</given-names></name><name name-style="western"><surname>Bellomo</surname><given-names>R</given-names></name><name name-style="western"><surname>Bakker</surname><given-names>J</given-names></name></person-group>. <article-title>The ten pitfalls of lactate clearance in sepsis</article-title>. <source>Intensive Care Med</source><year>2019</year>;<volume>45</volume>:<fpage>82&#8211;85</fpage>.<pub-id pub-id-type="pmid">29754310</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00134-018-5213-x</pub-id><pub-id pub-id-type="pmcid">PMC6334727</pub-id></mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>James</surname><given-names>JH</given-names></name><name name-style="western"><surname>Luchette</surname><given-names>FA</given-names></name><name name-style="western"><surname>McCarter</surname><given-names>FD</given-names></name><etal/></person-group>. <article-title>Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis</article-title>. <source>Lancet</source><year>1999</year>;<volume>354</volume>:<fpage>505&#8211;08</fpage>.<pub-id pub-id-type="pmid">10465191</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(98)91132-1</pub-id></mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kraut</surname><given-names>JA</given-names></name><name name-style="western"><surname>Madias</surname><given-names>NE</given-names></name></person-group>. <article-title>Serum Anion Gap: its uses and limitations in clinical medicine</article-title>. <source>Clin J Am Soc Nephrol</source><year>2007</year>;<volume>2</volume>:<fpage>162</fpage>.<pub-id pub-id-type="pmid">17699401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2215/CJN.03020906</pub-id></mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heffernan</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Judge</surname><given-names>S</given-names></name><name name-style="western"><surname>Petrie</surname><given-names>SM</given-names></name><etal/></person-group>. <article-title>Association between urine output and mortality in critically ill patients: a machine learning approach</article-title>. <source>Crit Care Med</source><year>2022</year>;<volume>50</volume>:<fpage>e263</fpage>&#8211;<lpage>71</lpage>.<pub-id pub-id-type="pmid">34637423</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CCM.0000000000005310</pub-id></mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bianchi</surname><given-names>NA</given-names></name><name name-style="western"><surname>Altarelli</surname><given-names>M</given-names></name><name name-style="western"><surname>Monard</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Identification of an optimal threshold to define oliguria in critically ill patients: an observational study</article-title>. <source>Crit Care</source><year>2023</year>;<volume>27</volume>:<fpage>207</fpage>.<pub-id pub-id-type="pmid">37254158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13054-023-04505-7</pub-id><pub-id pub-id-type="pmcid">PMC10228087</pub-id></mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cai</surname><given-names>G</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Fluid intake-related association between urine output and mortality in acute respiratory distress syndrome</article-title>. <source>Respir Res</source><year>2020</year>;<volume>21</volume>:<fpage>24</fpage>.<pub-id pub-id-type="pmid">31937303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12931-020-1286-5</pub-id><pub-id pub-id-type="pmcid">PMC6961352</pub-id></mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borges</surname><given-names>A</given-names></name><name name-style="western"><surname>Bento</surname><given-names>L</given-names></name></person-group>. <article-title>Organ crosstalk and dysfunction in sepsis</article-title>. <source>Ann Intensive Care</source><year>2024</year>;<volume>14</volume>:<fpage>147</fpage>.<pub-id pub-id-type="pmid">39298039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13613-024-01377-0</pub-id><pub-id pub-id-type="pmcid">PMC11413314</pub-id></mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nates</surname><given-names>JL</given-names></name><name name-style="western"><surname>P&#232;ne</surname><given-names>F</given-names></name><name name-style="western"><surname>Darmon</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Septic shock in the immunocompromised cancer patient: a narrative review</article-title>. <source>Crit Care</source><year>2024</year>;<volume>28</volume>:<fpage>285</fpage>.<pub-id pub-id-type="pmid">39215292</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13054-024-05073-0</pub-id><pub-id pub-id-type="pmcid">PMC11363658</pub-id></mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Prediction of median survival time in sepsis patients by the SOFA score combined with different predictors</article-title>. <source>Burns Trauma</source><year>2020</year>;<volume>8</volume>:<fpage>tkz006</fpage>.<pub-id pub-id-type="pmid">32346543</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/burnst/tkz006</pub-id><pub-id pub-id-type="pmcid">PMC7175770</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>